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The cerebral ventricular system consists of four interconnected ventricles containing 
cerebrospinal fluid (CSF). CSF is produced by a network of ependymal cells in the 
choroid plexus, which is located within the ventricles, and flows from the lateral 
ventricles through the foramina of Monro into the third ventricle, and subsequently 
through the cerebral aqueduct to the fourth ventricle (Figure 1.1). From there it either 
passes into the central canal of the spinal cord or into the cisterns of the subarachnoid 
space, via the central foramen of Magendie and the two lateral foramina of Luschka. 
The CSF is reabsorbed into the dural sinuses via arachnoid villi and enters the venous 
system. CSF provides buoyancy to the brain as well as protection from abrupt 
movements, facilitates the removal of waste metabolites, and has a role in the repair of 
the central nervous system.1 
 
 
Figure 1.1 The cerebral ventricular system 
Michael Schünke, Erik Schulte and Udo Schumacher, Thieme Atlas of Anatomy: Head and Neuroanatomy, 
Lawrence Ross, Edward Lamperti, Ethan Taub, 2006, copyrighted by Georg Thieme Verlag, Stuttgart, 
Germany, www.thieme.com (reprinted with permission)  
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CSF harbors information not yet tapped into. The distinction on Magnetic Resonance 
Imaging (MRI) between the cortical gray and subcortical white matter is known to 
decrease with aging. With a decrease in contrast between gray and white matter 
structures, volumetric assessment of brain structures that are not surrounded by CSF 
becomes more challenging. The sharp distinction between ventricles and brain 
parenchyma however is not influenced by aging, ensuring reliability of segmentation 
techniques despite older age. Ventricular shape and size may be analyzed as an indirect 
measure of cerebral atrophy. 
 
Variations in ventricular shape and size are well known to exist in the normal 
population. Ventricular dilatation is one of the imaging hallmarks of the aging process. 
Abnormal ventricular enlargement may be divided into non-communicating 
(obstructive) and communicating hydrocephalus. Causes of non-communicating 
hydrocephalus may be congenital (aqueduct atresia / stenosis or posterior fossa 
malformations) or acquired (infectious, neoplastic or secondary to intracranial 
hemorrhage). Communicating hydrocephalus may be ex vacuo in response to brain 
parenchyma loss, for instance in cerebral atrophy or traumatic brain injury, or may be 
part of the syndrome of Normal Pressure Hydrocephalus (NPH, a triad of gait disorder, 
cognitive dysfunction and bladder dysfunction in the setting of disproportionate 
ventricular dilatation). 
 
It is essential to differentiate between the expected ventricular dilatation in aging and 
abnormal ventricular changes. This differentiation can be challenging. Several methods 
have been devised to facilitate the distinction of normal and abnormal ventricular 
dilatation. Ventricular size can be measured using the frontal horn ratio (width of 
frontal horns divided by the internal diameter of the vault at the same level), bicaudate 
ratio (width of ventricles between caudate nuclei divided by the internal diameter of 
the vault at the same level) or Evans' index (width of frontal horns divided by the 
greatest internal diameter of the vault) on axial CT and MRI images.2 More precise post-
processing methods can segment brain tissue and CSF, after which a ventricle to brain 
ratio or ventricular to intracranial volume ratio can be calculated. 
 
Differentiation between normal and abnormal ventricular enlargement is all the more 
relevant in the case of NPH, since a select number of patients with NPH may benefit 
from ventricular shunt surgery, making this one of the few potentially reversible 
dementia syndromes. In typical NPH there is a discrepancy between the volume of the 
ventricles and peripheral CSF volume, with disproportionate enlargement of the 
ventricular volume. No specific quantitative measure for disproportionate ventricular 
dilatation has yet been described.3 The prevalence of this particular type of ventricular 
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dilatation in the general population is not known, and the possible functional 
consequences are not clear. 
 
The etiology of ventricular dilatation in NPH is not known. Early theories on altered CSF 
resorption have given way to thoughts on a vascular origin. The presence of reduced 
cerebral blood flow (CBF) in NPH is well established.4,5 Furthermore, intracranial 
vascular compliance was found to be significantly different in patients with NPH.6 The 
theoretical background to decreased intracranial vascular compliance leading to NPH 
was set out in a landmark paper from 2004, suggesting that decreased intracranial 
compliance causes restricted arterial pulsations and increased capillary pulsations, 
resulting in increased pulse pressure in the brain capillaries that maintain the 
ventricular enlargement in chronic communicating hydrocephalus.7 A later study 
proposed a “two hit” pathophysiology: “benign external hydrocephalus” in infancy 
followed by deep white matter ischemia in late adulthood.8 The problem with the 
placement of ischemia at the center of the etiology of NPH is that not all patients have 
ischemia.9 This was emphasized in a study based on PET/MRI data that found mean CBF 
to be reduced in NPH patients, but a standard deviation that was wide enough to 
theoretically place 16% of patients with NPH within the normal range.10 At present, 
altered hemodynamics seem to be the most plausible cause of NPH.9 
 
NPH is not the only dementia syndrome with enlarged ventricles as an imaging feature, 
highlighting the need for additional tools to differentiate this condition from other 
diseases with a similar clinical presentation. Moreover, the most common dementia 
syndromes all have an element of atrophy in general, or ventricular dilatation in 
particular. Alzheimer’s disease (AD) is characterized by medial temporal lobe atrophy. In 
an advanced stage this results in dilatation of the temporal horn of the lateral 
ventricles.11 Vascular dementia may lead to enlarged ventricles as a result of 
periventricular parenchymal loss due to ischemia or hemorrhage. Global cerebral 
atrophy in Parkinson’s disease and Dementia with Lewy Bodies, as well as 
frontotemporal atrophy in Frontotemporal dementia may all appear as ventricular 
dilatation. 
Aims of this thesis 
The general aim of this thesis was to study the causes and consequences of ventricular 
dilatation in aging and dementia. Additional objectives to support this aim were to 
design a measure that may objectively quantify the disproportionate ventricular 
dilatation that is characteristic to NPH, to study the value of such a measure for the 
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selection of candidates with NPH for ventricular shunting, to study the shape and size of 
the ventricles in relation to dementia syndromes, and to investigate potential new MRI 
markers of cognitive decline in both aging and AD. 
Outline of this thesis 
In an exploratory study prior to this thesis we searched for potential ventricular shape 
based biomarkers to discriminate between patients with AD and healthy elderly. An 
innovative technique for fully automatic shape modeling was applied to generate 
comparable meshes of all ventricles, permitting a point-by-point comparison of the 
ventricular surface. Potential biomarkers were then used to build an intelligent machine 
for AD detection, which was subsequently tested on previously unseen cases. 
 
Building on evidence of focal atrophy of periventricular structures in AD in said study, 
the same method of modeling and analyzing local shape variations of ventricles was 
applied to a wider spectrum of cognitive levels in chapter 2. Each participant was 
assessed with the Mini-Mental State Examination, yielding a study sample ranging from 
cognitively healthy to mild cognitive impairment, and from mild to advanced AD. The 
severity of periventricular atrophy was estimated as local enlargement of the 
ventricular surface relative to an average normal subject, and the extent of atrophy was 
defined as the percentage of the ventricular surface significantly different from an 
average control. Linear regression across subjects was performed to evaluate the 
correlation between atrophy and MMSE score. 
 
In chapter 3 the method of ventricular shape modeling was directed towards 
investigating possible local shape differences between cognitively healthy and persons 
with subjective memory complaints. Subjective memory complaints are common in the 
elderly, and are considered to be part of the spectrum that ranges from normal 
cognition to dementia. Though the memory complaints cannot be substantiated with 
formal cognitive testing, previous publications described cerebral atrophy on MR 
images of elderly with memory complaints, as well as AD type pathology on 
postmortem examinations.12 
 
Shunt surgery remains the standard treatment for NPH, despite high morbidity rates 
and lack of evidence indicating that shunt placement is effective in the management of 
this condition. Many diagnostic procedures have been described that may increase the 
probability of selecting the appropriate candidates for shunt surgery. In chapter 4 we 
studied the potential of volumetric assessment to distinguish between patients who 
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respond to ventricular shunt surgery and those who do not. The preoperative ratio of 
ventricular volume and sulcal CSF volume was correlated with postoperative 
improvement in gait impairment, cognitive impairment, and bladder function. 
 
In chapter 5 we investigated the prevalence of disproportionate ventricular dilatation 
(expressed as the upper quartile of the ratio of ventricular volume and sulcal CSF 
volume) in a cohort of elderly persons from the general population. In addition, we 
studied the association of disproportionate ventricular dilatation with symptoms from 
the NPH triad, consisting of gait impairment, cognitive impairment, and urinary 
incontinence. Since patients with white matter hyperintensities (WMH) or subcortical 
arteriosclerotic encephalopathy often present with an enlarged ventricular system and 
symptoms similar to those seen in NPH, the associations were adjusted for WMH 
volume and cardiovascular risk factors. 
 
Elaborating on earlier studies that suggested a vascular origin of disproportionate 
ventricular dilatation in NPH, in chapter 6 we hypothesized that ventricular volume out 
of proportion to sulcal CSF volume is caused by white matter atrophy resulting from 
small vessel disease. In order to quantify disproportionate ventricular dilatation, we 
used the ratio of ventricular volume and sulcal CSF volume. Small vessel disease was 
expressed as WMH volume. Linear regressions were used to study the relationship 
between WMH volume, ventricular volume, sulcal CSF volume, and the ratio of 
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In this work, we aimed at correlating focal atrophy in periventricular structures with 
cognitive function, in the spectrum from healthy subjects to severe Alzheimer’s disease: 
28 subjects with normal cognition and 84 patients presenting various degrees of 
cognitive impairment were included in the study. The cognitive level of each subject 
was assessed with the Mini-Mental State Examination (MMSE). Atrophy in 
periventricular structures was inferred by modeling and analyzing local shape variations 
of brain ventricles: for a given subject, we distinguished between the severity of 
atrophy, estimated as local enlargement (in mm) of the ventricular surface relative to an 
average normal subject, and the extent of atrophy, defined as the percentage of the 
ventricular surface (global or per anatomical region) significantly different from an 
average control. Linear regression across subjects was performed to evaluate the 
correlation between atrophy and MMSE score. The severity of atrophy showed good 
correlation with MMSE score in the left thalamus, the left temporal horn, the left 
corona radiata, and the right caudate nucleus. The extent of atrophy showed no 
significant correlations. In conclusion, the MMSE scores correlate with localized depth 




Dementia is usually defined as a progressive decline of cognitive function. Among the 
several possible causes of dementia, Alzheimer’s disease (AD) is usually regarded as the 
most common one. Considering the spectrum of cognitive function, healthy subjects are 
at one end, presenting normal cognitive level, while patients with severe Alzheimer’s 
disease (AD) are at the very opposite side. An important intermediate position is 
represented by mild cognitive impairment (MCI): patients suffering of MCI experience 
isolated memory deficits (amnesia), but are otherwise cognitively capable and not 
limited in their daily life. Growing evidence of how AD affects brain structures has 
previously been presented: hippocampal atrophy;1-5 rapid degeneration of prefrontal 
lobe;6,7 atrophy of entorhinal cortex;8-11 pronounced atrophy of the corpus callosum.12-
14 Similar studies have analyzed the effects of MCI and its relationship with AD.15-17 
 
Several cognitive tests exist to assess the cognitive level of an individual. One of them, 
the Mini-Mental State Examination (MMSE),18 has largely been used in clinical practice 
for the diagnostic work up of AD and MCI. Conspicuous attempts to correlate MMSE 
scores with brain structural changes, as captured by magnetic resonance imaging (MRI), 
have recently been reported in the literature: Thompson et al.19 showed high 
correlation in AD between MMSE scores and changes in temporal horns; Duan et al.20 
showed high correlation between cognitive impairment and selective white matter 
damage in AD, measured as a reduction of fractional anisotropy, particularly in the 
splenium of the corpus callosum; Apostolova et al.15 investigated the correlation 
between MMSE scores and hippocampal volume changes, finding no significant 
correlation in MCI-converters (among the subjects affected by MCI, some convert in 
time into AD and are referred to as MCI converters); Baxter et al.21 showed high 
correlation in AD between MMSE scores and decrease of gray matter in the left 
temporal lobe; finally, a strong correlation between MMSE scores and gray matter loss 
in several cortical regions was observed in clinical and pre-clinical AD.22 
 
The aim of our study was to investigate to what extent the MMSE score correlates with 
atrophy in periventricular structures. Any change in volume or shape in these structures 
must be reflected on the shape and volume of the brain ventricles: thus, by analyzing 
shape variations in the entire ventricular system we could indirectly estimate the 
degree of atrophy in all the periventricular structures. The delineation of small gray and 
white matter structures is a challenging task, particularly in elderly subjects, due to the 
loss of contrast between different tissues:23 (semi-)automatic segmentation is error 
prone and not always reproducible, while manual delineation is highly time consuming. 
Cerebrospinal fluid (CSF), on the other hand, can be automatically and reliably 
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segmented, thanks to its sharp contrast with respect to the rest of the parenchyma. 
While analyzing atrophy, we introduced a distinction between the severity of atrophy 
and the extent of atrophy. The former was estimated as local enlargement (in mm) of 
the ventricular surface with respect to a normal average case; the latter was given by 
the percentage of ventricular surface significantly different from an average normal 
case. Finally, rather than focusing on only one specific pathological condition, such as 
AD or MCI, we included subjects from both groups, covering a larger area in the 
spectrum of cognitive impairment. 
Materials and Methods 
Subjects 
The subjects included in the study were chosen so that a large area in the spectrum of 
cognitive function could be represented: 28 volunteers with normal cognitive function, 
and 84 patients presenting different degrees of cognitive impairment (26 subjects with 
MCI and 58 patients affected by AD, ranging from mild to severe cases). The volunteers 
were recruited through advertisements in local newspapers, while patients with 
cognitive impairment were consecutively referred to our outpatient memory clinic. The 
cognitive status was evaluated for all subjects using a standardized dementia screening, 
including a detailed medical history, a general internal and neurological exam, 
laboratory tests, neuropsychological testing (i.e., MMSE), and magnetic resonance 
images of the brain. Diagnoses were made in a multidisciplinary consensus meeting, 
according to the National Institute of Neurological and Communicative Disorders and 
Stroke–Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria 
for probable AD, and the Petersen criteria for MCI. Table 3.1 shows the demographic 
data: t tests performed on age and sex showed no significant difference between 
groups (p < 0.01). Subjects were included if they were older than 60 years, had no other 
neurologic or psychiatric illness, and had no abnormalities on MRI other than white 
matter hyperintensities or an incidental small lacunar lesion (≤ 5-mm diameter). 
Approval by the local Medical Ethical Committee was granted to the study. Written 




Table 3.1 Demographic data: total number of subjects  
per group (and total number of male), age (in years), and MMSE score 
 Controls Patients
Tot (N male) 28 (12) 84 (38)
Age μ (σ) 74 (6.9) 74 (7.3)
MMSE μ (σ) 27.6 (1.7) 20.8 (5.6)
 [min–max] [24–30] [4–30]
 
MRI acquisition and image pre-processing 
Magnetic resonance images were acquired on a 1.5-T MR-system (Philips Medical 
Systems, Best, The Netherlands) using the following pulse sequences: dual fast spin-
echo (proton density and T2 weighted): time to echo (TE) 27/120 ms, repetition time 
(TR) 3000 ms, 48 contiguous 3-mm slices without an interslice gap, matrix 256 × 256, 
field of view (FOV) 220 mm; FLAIR (fluid attenuated inversion recovery): TE 100 ms, TR 
8000, 48 contiguous 3-mm slices without an interslice gap, matrix 256 × 256, FOV 220 
mm. 
 
Images were pre-processed with our in-house developed automatic segmentation 
software,24 which automatically extracted the intracranial cavity, the CSF, and the white 
matter hyperintensities. Three-dimensional region growing was applied to re-label the 
ventricular CSF as ventricles. Automatic affine 12-parameter image registration,25 was 
applied to normalize all the images and the ventricular segmentations to the LUMC T2-
weighted brain template for geriatrics,26 in order to correct for brain size and 
orientation. 
Shape modeling 
The measure of focal atrophy in periventricular structures is based on the 
corresponding deformations occurring in the shape of the brain ventricles. Thus, as a 
first step one needs to model all the brain ventricles with comparable meshes. This was 
done with an automatic modeling technique previously introduced in Ferrarini et al.:27 
the healthy subjects are used to generate an average brain ventricle image, whose 
surface is modeled by a growing and adapting mesh (see Fig. 3.1 (top)); subsequently, 
the mesh's structure is frozen (nodes are not added nor removed), and the mesh's 
shape is automatically adapted to all the ventricles in the study, ending up with 
comparable meshes (i.e., each node in a given mesh is uniquely associated with 
corresponding nodes in the other meshes). Local changes in ventricular shapes should 
be associated with focal atrophy in periventricular structures: thus, an expert was asked 
to manually delineate several regions on the initial average ventricular volume, each 
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corresponding to an adjacent periventricular structure. Nodes in the first mesh were 
then labeled accordingly to the closest region (see Fig. 3.1 (bottom)), and labels were 
propagated to all the other meshes. We visually inspected the results across all the 
meshes, to guarantee correct correspondence between labels and adjacent 
periventricular structures. In the remaining of this paper, the terms region left (right) 
corona radiata, region left (right) caudate nuclei, etc., will refer to the sets of nodes 




(Top) Shape modeling of an average ventricle: a mesh grows and adapts to model an average control surface. 
(Bottom) The ventricle volume was manually divided in regions, according to the adjacent periventricular 
structures, and each node was labeled accordingly.  
Pre-statistical shape analysis 
Does MMSE score correlate with severity of focal atrophy? 
We have assessed the significance of the correlation between the severity of focal 
atrophy and MMSE score for each location (i.e., node) on the ventricular surface. 
Considering a particular node in a given subject, one can evaluate its Euclidian distance 
in space to the corresponding node in the average mesh, obtained from the control 
group. The underlying idea is that focal atrophy in periventricular structures should lead 
to a more pronounced local ventricular enlargement, and subsequently to larger 
distances between a given node and the corresponding one in the average control. We 
visually checked that all the non-control ventricles presented larger structures than the 
average control. For each node, the local enlargements across all subjects were 
correlated with the corresponding MMSE scores: the statistical analysis and the results 
are reported in the MMSE correlation with severity of atrophy section. 
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Does MMSE score correlate with the extent of atrophy? 
A similar approach was taken to evaluate the correlation between the MMSE score and 
the extent of atrophy. Starting with the average mesh previously introduced, for each 
node i we modeled the local distribution in space of the control population, evaluating 
the average distance μi and the standard deviation σi (with i = 1, 2, …, NNodes) (see Fig. 
3.2). Subsequently, considering a subject j, for each node i we evaluated its Euclidian 
distance di
j to the corresponding node in the average mesh. The location i in subject j 





Extent of atrophy measurement. (a) Spatial distribution of the control population around node i of the 
average shape. (b) Average distance μi and threshold μi+3σi. (c) In a shape j, the node i is labeled as 1 if its 
distance from the average node is higher than the threshold. (d) The extent of atrophy is the percentage of 
nodes set to 1.  
 
For each subject and for each region, we could therefore evaluate the percentage of 
locations set to 1, corresponding to the local extent of atrophy. Such values were finally 
correlated, across all subjects, with the MMSE scores: permutation tests were used to 
assess the significance level (p-value) of the correlation. Results are reported in the 
MMSE correlation with extent of atrophy section. 
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Results 
MMSE correlation with severity of atrophy 
For each given node, we performed a linear regression correlating local distances of all 
subjects from the control average node, to the MMSE scores associated with the 
subjects. The statistical significance of the correlation was assessed via permutation 
tests, correcting for multiple comparisons. Thus, the results provided us, for each node, 
with a p-value indicating the significance of the correlation in that particular location. 
Mapping the p-values on an average control, we could visually highlight areas with 
higher correlation (see Fig. 3.3). Results were then clustered into the manually 
delineated regions, and for each region we evaluated the percentage of surface in 
which the severity of atrophy significantly correlated with the MMSE score: this made it 
possible to identify the regions (and, consequently, the periventricular structures) with 
higher correlation. Fig. 3.4 shows the percentage of area in which the severity of 
atrophy correlates (p < 0.05) with the MMSE score, for each manually delineated region 
(the whole, left, and right ventricular systems are also considered). Some regions show 
a high correlation: left corona radiata, right caudate nucleus, left caudate nucleus, left 
thalamus, and left medial temporal horn. Other regions, on the other hand, are almost 
completely uncorrelated: right side of the corpus callosum, right side of the thalamus, 
left inferior medial temporal horn. It is notable that the severity of atrophy in left 
periventricular structures (reflected in the left ventricular system) presents a higher 
correlation with the MMSE score than those on the right. 
MMSE correlation with extent of atrophy 
We performed a linear regression analysis to correlate the MMSE score and the extent 
of atrophy for the whole, left, and right ventricular systems, as well as for each of the 
manually delineated regions. All subjects were included in the analysis, and both the R2 
statistic and the corresponding p-value were evaluated. Results are reported in Table 
3.2. No significant correlation was found in any of the analyzed areas. Only in the left 
inferior medial temporal horn we could detect a trend, showing that higher MMSE 
scores reflect smaller extents of atrophy: nevertheless, the correlation was not 
significant (p-value = 0.06). The results were not corrected for multiple comparison: 
even without correction, no significant correlation was detected, supporting the idea 





Local correlation between severity of atrophy and cognitive impairment, across all subjects (controls and 





Extent of correlation for the severity of atrophy. For each region, we plot the percentage of ventricular 
surface whose severity of atrophy (see Fig. 3.3) significantly correlates with the MMSE score.  
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Table 3.2 Linear regression between extent of atrophy and MMSE score (all 112 subjects included): for each 
area, we report the R2 value and the corresponding p value. No significant correlation was found (p threshold 
set at 0.05). 
  R2 p-Value
Whole ventricle  0.01 0.67
Right ventricle  10− 6 1.00
Left ventricle  0.03 0.40
Corona radiata R 0.01 0.66
L 0.01 0.75
Corpus callosum R 0.03 0.39
L 0.01 0.70
Caudate nuclei R 0.03 0.39
L 0.03 0.43
Thalamus R 0.001 0.88
L 10− 4 0.94
Superior medial temporal horn R 10− 4 0.92
L 0.05 0.31
Inferior medial temporal horn R 0.003 0.78
L 0.14 0.06
Discussion and conclusions 
In this work, we have investigated the correlation between atrophy in periventricular 
structures and cognitive function, in the spectrum from normal cognition to severe AD. 
The analysis of structural changes in periventricular structures always presents some 
serious challenges. First, one should choose between volumetric or shape-based 
analyses. In Van der Flier et al.,28 the authors analyzed a subset of the population used 
in this study, showing that MR volumetric measurements of the brain correlate with 
cognitive decline in non-demented elderly. The volume changes, being inherently 
global, are less subject to small segmentation errors; shape-based methods, on the 
other hand, aiming at a localized analysis, are more sensitive to the accuracy of the 
segmentation. Conversely, the volumetric distributions of periventricular structures in 
normal and non-normal populations might overlap and fail to provide discriminative 
results; shape analysis, highlighting more localized differences, is less keen to this 
problem. Thus, a shape analysis of periventricular structures is to be preferred. 
Unfortunately, the intensity contrast between white and gray matter decreases with 
age,23 making it a more difficult and less accurate task to delineate periventricular 
25 
structures in MR. On the other hand, the contrast between CSF and the remaining 
parenchyma stays sharp in elderly, allowing automatic tools to reliably segment 
ventricular CSF. In our study, we have analyzed shape changes of the whole ventricular 
system as an indirect tool to investigate atrophy in the surrounding periventricular 
structures: this differs from previous methods which focused more on singular 
gray/white matter structures or specific ventricular areas. 15,19-20 Moreover, we 
introduced a clear separation between severity of atrophy and extent of atrophy, 
showing that the former correlates with cognitive impairment, while the second does 
not: while doing this, we explored a large area in the spectrum of cognitive function, 
including both subjects with MCI and AD, while previous methods focused more on 
AD,19-20 on AD and a limited number of converting MCI,22 or on converting and non-
converting MCI.15 
 
The assessment of a subject's cognitive function is not a trivial task. In this work, we 
have chosen to use the MMSE score as an estimation of an individual's cognitive level. 
This choice was justified by the fact that, despite its limitations, the MMSE score is 
largely used in the diagnostic work up of AD and MCI in clinical routine. Thus, a better 
understanding of how the MMSE score relates to periventricular atrophy is important. 
Global measurements of brain atrophy have already been proved to correlate with 
MMSE scores.29-30 The local analysis presented in this work aimed at further improving 
our knowledge on how damage in specific periventricular structures contributes to the 
assessment of an individual's cognitive level. 
 
The results lead to some further considerations. The severity of cognitive impairment 
seems to correlate significantly with increased severity of atrophy in well-defined 
periventricular structures. More specifically, areas like the left corona radiata, right and 
left caudate nuclei, left side of the thalamus, left medial temporal horn, and the left side 
of the splenium in the corpus callosum showed high correlation between severity of 
atrophy and cognitive impairment. These findings are in agreement with those 
previously reported in the literature: a correlation between dementia and infarcts in the 
left corona radiata was highlighted in Pohjasvaara et al31 the left temporal horn and its 
correlation with dementia is well-established,15 Thompson et al.,19 and shows how 
atrophy of the temporal lobe and hippocampus is inherently related with the disease; 
involvement of the left side of the splenium in the corpus callosum was highlighted by 
Duan et al.,20 by using global diffusion tensor images for healthy subjects and ADs. 
Thompson et al.19 suggested that a lack of correlation between cognitive decline and 
hippocampal atrophy might be due to the MMSE test itself, since it is mostly related 
with cortical functions. Our findings on the thalamus might lead to some further 
considerations: the thalamus is responsible to code and transmit information to the 
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cortex, particularly for what concerns the sensory system (auditory system, visual 
system, etc.): thus, impairments of cortical functions might also occur as a consequence 
of thalamus deficits. Finally, looking at the whole, left, and right ventricular systems, it is 
clear that the severity of atrophy in the left hemisphere presents a higher correlation. 
This result is consistent with previous studies showing how changes in left 
periventricular structures relate to MCI and AD: particularly Scher et al.32 showed 
consistent patterns of shape differences in AD in the body of the left hippocampus; 
Whitwell et al.33 showed gray matter loss in the left anterior inferior temporal lobe in 
nonamnestic MCI; Yavuz et al.34 correlated MMSE scores with volume loss of both left 
and right hippocampi; finally Müller et al.35 showed that the left hippocampus volume is 
an accurate diagnostic variable for MCI. When we tried to correlate the extent of 
atrophy with cognitive function, we could not find any significant result. The only 
exception was the left inferior medial temporal horn, which presented an almost 
significant correlation (p = 0.06). 
 
The assumption that MMSE scores can confidently reflect cognitive impairment is open 
to discussion. Neuropsychological tests usually provide a large set of indicators to 
estimate the cognitive level of an individual. The MMSE test is a global composite 
measurement of different cognitive functions, spatially located in different parts of the 
brain. Some criticisms have been moved to the use of MMSE test, especially when 
assessing the cognitive level of healthy subjects or patients with MCI. Nevertheless, the 
MMSE test keeps being intensively used in the diagnosis of AD and MCI: thus, efforts to 
improve our understanding on its relation with brain structural changes are largely 
justified. To the best of our knowledge, this is the first study which clearly distinguishes 
between different kinds of atrophy in periventricular structures and correlates them 
with cognitive impairment in MCI and AD, as estimated by the MMSE score. 
 
In conclusion, our results suggest that worse MMSE scores correlate with an increased 
severity of atrophy in well-defined periventricular structures. Future research might 
focus on other global tests, such as the Camcog, and more specific cognitive tests: a 
comparison between tests could strength even further the link between cognitive 
impairment and atrophy of well-defined periventricular structures. 
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Cerebral atrophy in elderly with 
subjective memory complaints 
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To evaluate ventricular shape differences along the complete surface of the lateral and 
third ventricles of persons with subjective memory complaints (MC). 
 
We included 28 controls and 21 persons with MC. FLAIR, T2 and PD-weighted brain MRI 
scans were acquired at 1.5 T, followed by semi-automated segmentation of the lateral 
and third ventricles, and local shape difference analysis based on growing and adaptive 
meshes. Ventricular meshes were used to highlight local areas with significant 
differences between controls and persons with MC, determined by permutation tests 
with a predefined threshold (p = 0.01). 
 
Compared to control subjects, relevant differences were found in the shape of the 
ventricular surface adjacent to the thalamus and corona radiata in persons with MC. 
Before correction for multiple comparisons, relevant differences were also found in the 
shape of the ventricular surface adjacent to the corpus callosum, hippocampus and 
amydala. 
 
Our findings suggest the presence of localized structural brain differences in patients 




Subjective memory complaints are common in the elderly.1 They are considered to be 
part of the spectrum that ranges from normal cognition to dementia.2 Memory 
complaints are a core feature of Mild Cognitive Impairment (MCI), but in MCI these 
complaints can be verified with cognitive testing.3 However, a fair number of elderly 
have memory complaints that cannot be substantiated with formal cognitive testing. 
The presence of subjective memory complaints significantly increases the risk of future 
cognitive decline,4 however, not as significant as in MCI, which leads to dementia in 
about half the cases.3 Furthermore, Alzheimer’s disease (AD) pathology has been 
observed in persons with subjective memory complaints on post-mortem examination, 
including amyloid plaques and neurofibrillary tangles.5 It has been suggested that 
memory complaints in older persons may indicate self-awareness of a degenerative 
pathologic process.5 
 
Using segmentation techniques on MR images, atrophy has been detected in persons 
with subjective memory complaints in two specific regions of the brain: the corpus 
callosum (6) and hippocampus.7-9 Segmentation of these structures is relatively simple, 
since a large part of these structures is surrounded by CSF, offering a sharp contrast 
that increases the reliability of segmentation techniques. However, segmentation of 
other brain structures that are not surrounded by CSF is more challenging since the 
borders of these structures are less clear. Furthermore, due to the aging process, such 
borders may fade away, further complicating segmentation. The border between the 
cortical gray and subcortical white matter in particular is known to lose contrast with 
aging. Lack of reliable tools to segment the basal ganglia and thalamus is one of the 
reasons why involvement of these structures in subjective memory complaints has not 
been assessed thus far. 
 
The shape of the cerebral ventricles may be analyzed as an indirect measure of cerebral 
atrophy. Since atrophy of periventricular structures results in compensatory changes 
(local dilatation) in ventricular shape, this method offers a reliable way to detect 
atrophy in periventricular structures. The advantage of this technique is that it relies on 
the high contrast border between ventricles and brain parenchyma. This method has 
been validated10 and applied in patients. In patients with AD, it detected shape 
differences on the ventricular surface of the medial temporal horn, the corpus 
callosum, the thalamus and the caudate nucleus.11 
 
In the present, explorative study we compare the ventricular shapes of persons with 
subjective memory complaints to those of control subjects. Our aim is to search for 
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localized shape differences in the complete ventricular surface of persons with 
subjective memory complaints, as an indirect measure of regional atrophy in adjacent 
periventricular gray matter structures. 
Materials and Methods 
Subjects 
Twenty-one consecutive self-referred persons with subjective memory complaints from 
the outpatient memory clinic of our institution participated in this study. The diagnosis 
of subjective memory complaints was made in the absence of abnormalities in 
neuropsychological test results, according to age and educational level. Twenty-eight 
elderly controls without memory complaints were recruited through an advertisement 
in a local newspaper. The study was approved by the institutional review board. Written 
informed consent was obtained from all persons. Table 4.1 shows the demographic 
data of our study sample. Controls did not differ from memory complainers in age 
(Independent Samples T-test, p = 0.08) or gender (Fisher’s Exact Test, p = 0.56). 
 
Table 4.1 Demographics and Neuropsychological Assessment 
 Controls Subjective MC P-value
Total 28 21
Males, percentage 12, 43% 7, 33% 0.56
Age, mean 74.1 (6.9) 70.4 (7.3) 0.08
CAMCOG, total score 95.9 (4.2) 93.8 (5.5) 0.12
MMSE 27.6 (1.7) 28.2 (1.7) 0.20
WMS, memory quotient 126.9 (11.9) 119.9 (16.0) 0.07
ADAS, total good score 19.2 (3.5) 18.1 (3.9) 0.31
Boston, score 25.4 (3.3) 25.0 (3.4) 0.67
FAS, good score 35.0 (12.1) 34.3 (10.3) 0.83
Benton, good score 5.2 (1.6) 5.4 (2.0) 0.71
TMT part A, time in seconds 33.5 (11.3) 51.8 (22.7) < 0.001
TMT part B, time in seconds 83.1 (32.6) 129.4 (54.6) 0.001
WAIS-R substitution, rough score 42.2 (8.7) 35.5 (9.0) 0.01
Standard deviations are presented in brackets. MC = Memory Complaints; CAMCOG = Cambridge Cognitive 
Examination; MMSE = Mini-Mental State Examination; WMS = Wechsler Memory Scale; ADAS = Alzheimer's 




All participants were subject to a standardized neuropsychological test battery. Global 
cognitive functioning was assessed using the Cambridge Cognitive Examination 
(CAMCOG) (12,13), which incorporates the Mini-Mental State Examination (MMSE).14 
The CAMCOG provides a total score for global cognitive functioning as well as subscores 
for specific cognitive functions (memory, orientation, language, praxis, and gnosis). 
Memory was also evaluated using the Wechsler Memory Scale (WMS)15 and word recall 
from the Alzheimer’s Disease Assessment Scale (ADAS)16. The Boston Naming Test17 was 
employed to yield an additional measure of language function. Tests of executive 
functioning included letter (FAS) and category (animals, jobs) fluency,18 the Trail Making 
Test (TMT)19 and the digit symbol subtest of the Wechsler Adult Intelligence Scale–
Revised.20 Neuropsychological test results were compared between controls and 
persons with subjective memory complaints using Independent Samples T-tests. Data 
from MMSE, WMS, Boston, TMT A and TMT B were skewed and were therefore first 
log-transformed. The TMT scores were significantly different, indicating a difference in 
executive functioning. However, our other neuropsychological tests showed no 
difference in memory and global cognitive performance. The diagnosis of memory 
complainer was made on the basis of a clinical assessment by the neuropsychological 
department of our institution. Overall, neuropsychological test results for memory 
complainers were within normal limits. 
MRI acquisition and analysis 
Magnetic resonance images were acquired on a 1.5-T MR-system (Philips Medical 
Systems, Best, The Netherlands) using a dual fast spin-echo (proton density and T2 
weighted) sequence: time to echo (TE) 27 ms, repetition time (TR) 3000 ms, 48 
contiguous 3-mm slices without an interslice gap, matrix 256 x 256, field of view (FOV) 
220 mm. The line through the inferior border of the genu and splenium of the corpus 
callosum defined the direction of scanning. Segmentation was performed using SNIPER 
(Software for Neuro-Image Processing in Experimental Research),21 an in-house 
developed software program, consisting of automatic 3D registration, automatic 
segmentation of intra-cranial cavity and CSF volumes, followed by manual labeling of 
lateral and third ventricles on CSF masks with semi-automatic region growing, and 
calculation of volumes. All the images were then corrected for head-size and 
orientation using automatic affine 12-parameters registration to the LUMC T2-weighted 
brain template for geriatrics.21,22 
Ventricular meshes 
Morphological analysis required, as a first step, the transformation of the brain 
ventricles into comparable ventricular meshes. This was performed following an 
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automatic procedure that has been described before.23 An average shape was created 
from the control population. This involved several steps: first, a voxel-count map was 
built up by adding all controls’ binary volumes; subsequently, a threshold was applied to 
the voxel-count map, obtaining an average control ventricle. GAMEs (Growing and 
Adaptive Meshes)10 was then applied to the average volume: initially, a mesh was 
grown (adding nodes and edges) until it converged to a good representation of the 
average control shape; once the first mesh was obtained, the number of nodes and 
edges was frozen. In a second phase the mesh was adapted to all the instances in the 
two populations using the Kohonen self-organizing map algorithm.24 Since nodes were 
not added nor removed, all the final meshes were comparable: each node in a given 
mesh was uniquely associated with another node in another mesh, allowing for local 
comparison between meshes. Local shape difference analysis was based on such 
comparable meshes, in which corresponding nodes were representative of similar 
anatomical locations. 
Ventricular surface parcellation 
In order to quantify the extent of local shape differences in the different groups and 
relate it to particular periventricular structures, we manually parcellated the total 
ventricular surface into regions, according to the adjacent anatomical structures: the 
left and right corona radiata, the left and right side of the corpus callosum, the left and 
right caudate nuclei, the left and right thalamus, the left and right superior medial 
temporal horns and the left and right inferior medial temporal horns. This manual 
delineation was performed only once, using a regular anatomical atlas, on the template 
used to normalize all the brain images.25 The parcellation procedure was performed by 
the first author (a resident physician in radiology) and second author (an information / 
software engineer), and verified by the last author (an experienced neuroradiologist). 
The software extracted fully automatically the intracranial cavity, the cerebrospinal fluid 
(CSF), and the white matter hyperintensities. The lateral and third ventricles were 
semiautomatically extracted by re-labeling the ventricular CSF to ventricles slice-by-
slice, using interactive editing tools. The mesh’s nodes were associated with the closest 
overlapping region, and clustered together in corresponding surface areas. The purpose 
of our manual delineation was to generate a meaningful regional parcellation of the 
ventricular surface, rather than to obtain an accurate delineation of the corresponding 
periventricular structures: such a parcellation allows a more detailed quantitative 
analysis of the differences between the groups. 
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Local shape difference analysis 
Ventricular volume was not normally distributed in our study subjects (Lilliefors test for 
normal distribution). A non-parametric test (Mann-Whitney U) was used to compare 
median ventricular volume between the two groups. 
 
Given two populations of brain ventricle meshes, permutation tests were applied at 
each node location to evaluate the significance of local shape differences: each location 
(i.e. node in the mesh) of the ventricles was associated with a p value, rendered with a 
color code on the ventricular surface, as shown in Figure 4.1. Locations with a p value 
below 0.01 were chosen as characteristic features for the brain ventricle’s shapes. To 
prevent coincidental findings, significant differences were considered only when at least 
1% of the nodes of a region proved significantly different. Displacement vectors were 
also evaluated at each location found to be significantly different: for our two groups of 
subjects, we generated two average meshes and evaluated the displacement in space 
between corresponding nodes. The direction of the displacement in the x, y and z 
directions was used to determine shrinkage (negative direction) or enlargement 
(positive direction) compared to controls. We found that the displacement was positive, 
indicating enlargement. Also, visual inspection of displacement vectors between 
controls and persons with subjective memory complaints showed that changes 
occurred as a result of enlargement of the ventricles in the group of subjects with 
subjective memory complaints. Ventricular shape differences between these groups 
were expressed as the percentage of nodes with significant displacement on the surface 




Figure 4.1 Ventricular shape comparison 
Transverse, coronal and sagittal views of local differences in ventricular shape between controls and persons 
with subjective memory complaints. Uncorrected local shape differences between groups are represented by 
color-coded p-values.  
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Finally, a False Discovery Rate (FDR) correction was added to our local shape difference 
analysis, for which a p-value below 0.2 was chosen to evaluate differences between 
controls and persons with subjective memory complaints. 
Results 
Localized ventricular shape differences between persons with subjective memory 
complaints and controls, as well as the total number of nodes for each area, are 
presented in Table 4.2. This table shows uncorrected results (P < 0.01), as well as results 
after FDR correction (P < 0.2). 
 
Table 4.2 Ventricular shape differences between controls and memory complainers 
 Total number
 of nodes 
P < 0.01 No FDR FDR P < 0.2 
% mm % mm 
Corona radiata R 88 0 - 0 - 
L 91 0 - 1 2.2 
Corpus callosum R 140 5 1.8 0 - 
L 153 2 0.7 0 - 
Caudate nucleus R 32 0 - 0 - 
L 30 0 - 0 - 
Thalamus R 50 2 0.9 0 - 
L 38 3 0.4 8 2.2 
Superior Medial Temporal Lobe R 99 2 1.3 0 - 
L 122 0 - 0 - 
Inferior Medial Temporal Lobe R 55 13 1.1 0 - 
L 51 2 1.3 0 - 
% = percentage of nodes on the surface of a given structure that show significant displacement; mm = 
average displacement per area in millimeters; FDR = False Discovery Rate. 
Corpus callosum 
Before FDR correction, relevant shape differences were found in the ventricular surface 
adjacent to the corpus callosum between persons with subjective memory complaints 
and controls. The right ventricular surface of the corpus callosum contained a larger 
percentage of different nodes (5%) than the left side (2%). In addition, average 
displacement was greater in the right ventricular surface of the corpus callosum (1.8 
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mm) than on the left (0.7 mm). After FDR correction, no nodes were found on the 
ventricular surface of the corpus callosum with significant displacement. 
Inferior medial temporal horn 
Before FDR correction, relevant shape differences were found in the ventricular surface 
of the inferior medial temporal horn between persons with subjective memory 
complaints and controls. The ventricular surface of the right inferior medial temporal 
horn contained a far larger percentage of different nodes (13%) than the ventricular 
surface of the left inferior medial temporal horn (2%). Average displacement was 
comparable between the ventricular surface of the right (1.1 mm) and left (1.3 mm) 
inferior medial temporal horns. After FDR correction, no nodes were found in the 
ventricular surface of the hippocampus with significant displacement. 
Thalamus 
Before FDR correction, relevant shape differences were found in the ventricular surface 
of the thalamus between persons with subjective memory complaints and controls. The 
ventricular surface of the left thalamus contained a larger percentage of different nodes 
(3%) than the ventricular surface of the right thalamus (2%). After FDR correction, 8% of 
the nodes in the ventricular surface of the left thalamus showed significant 
displacement, while no nodes with significant displacement were found in the 
ventricular surface of the right thalamus. 
Corona radiata 
Before FDR correction, no relevant shape differences were found between persons with 
subjective memory complaints and controls in the ventricular surface of the corona 
radiata. However, after FDR correction a single node (1% of the ventricular surface of 
the left corona radiata) showed significant displacement. 
Remaining periventricular structures 
For the ventricular surface of the superior medial temporal horn, a difference was only 
found on the right hemisphere (2% of nodes), which did not remain after FDR 
correction. Both before and after FDR correction, no relevant shape differences were 
found in the ventricular surface adjacent to the caudate nucleus. 
Discussion 
The main finding of our study is outward displacement of the ventricular surface 
adjacent to the thalamus and the corona radiata in persons with subjective memory 
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complaints, compared to controls. Uncorrected results showed tentative evidence of 
local shape differences in the ventricular surface of the corpus callosum, hippocampus 
(inferior temporal horn) and amygdala (superior temporal horn). Our results were based 
on segmentation of the lateral ventricles and third ventricle, which is amenable to 
robust automatic segmentation due to the sharp contrast between the signal intensity 
of CSF and surrounding tissue. 
 
The thalamus, a gray matter structure bordering the third ventricle, is involved in limbic 
circuitry and mediates or regulates numerous cognitive functions.26,27 It is involved in 
directing attention and suppressing irrelevant sensory input,28 and contributes to the 
function of memory.29 Size reduction of the thalamus following neurodegeneration has 
been linked to cognitive performance in Huntington’s disease,30 multiple sclerosis31 and 
Alzheimer’s disease32. Using automatic segmentation of the thalamus on three-
dimensional T1-weighted MR images, De Jong et al. found thalamic volume significantly 
reduced in patients diagnosed with probable AD.33 Braak et al. found that extracellular 
amyloid deposits and neurofibrillary tangles occur in the limbic nuclei of the thalamus.34 
As a secondary pathological pathway, subcortical small lesions in the thalamus may 
disrupt frontal-subcortical circuits, resulting in cognitive impairment of vascular origin 
superimposed on AD pathology.35 In the current study, persons with subjective memory 
complaints were found to have a different ventricular shape of the thalamus, suggesting 
that thalamic atrophy may play a role in the development of subjective memory 
complaints. The difference in percentage of displaced nodes before versus after FDR 
correction may be explained by the different p-values employed (P < 0.01 versus P < 
0.2). 
 
The corona radiata, a fibre bundle related to motor function, has been associated with 
information processing speed.36 Few publications describe a direct relationship 
between damage to the corona radiata and cognitive performance. Subtle cognitive 
impairment and emotional disturbances were found in patients with a single lacunar 
infarct in the corona radiata.37 To our knowledge, changes in the corona radiata have 
not been described in persons with subjective memory complaints. In the current study, 
there were no nodes with significant displacement in the ventricular surface of the 
corona radiata in the uncorrected analysis (P < 0.01), and a single node with significant 
displacement in the ventricular surface of the left corona radiata after FDR correction (P 
< 0.2). This remarkable finding indicates that, in addition to a role in motor function, the 
corona radiata may also be involved in cognitive function. 
 
The corpus callosum is the largest white matter structure in the brain that connects 
homologous cortical areas of the two cerebral hemispheres and plays a critical role in 
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transfer of sensory, cognitive and motor information.38 Callosal atrophy was found to be 
associated with impaired global cognitive function in a mixed elderly population.39 
Wang et al found a significant reduction in corpus callosum volume in persons with 
subjective memory complaints, compared to controls.6 The observed changes of the 
corpus callosum probably reflect atrophy in the cerebral hemispheres through 
Wallerian degeneration. Our uncorrected results tentatively concur with the body of 
evidence that reduction in the volume of the corpus callosum may be associated with 
subjective memory complaints. 
 
The hippocampus is a small inferior medial temporal lobe structure of a complex shape, 
which forms part of the limbic system40 and plays a central role in memory function.41,42 
The hippocampus is the site of the earliest neurofibrillary pathology in AD.42 Our 
uncorrected results showed shape differences in the ventricular surface adjacent to the 
hippocampus in persons with subjective memory complaints. Whether the brain 
changes in memory complainers are caused by neurofibrillary tangles and amyloid 
deposits as seen in AD, or ischemic changes is not known. Memory complaints have 
been associated with AD pathology on post-mortem examination, including both 
amyloid plaques and neurofibrillary tangles, suggesting that memory complaints in 
older persons may indicate self-awareness of a degenerative pathologic process.5 These 
early changes may be too subtle for detection by neuropsychological assessments. 
 
The amygdala is a complex structure in the medial temporal lobe consisting of several 
nuclei.43 It is located superior to the hippocampus, near the superior medial temporal 
horn. Numerous studies described significant atrophy of the amygdala in AD patients 
compared to normal controls.32,43-45 Whitwell et al. found gray matter loss in the 
amygdala approximately three years before progression from MCI to AD,46 confirming 
the proposed pathological staging scheme in AD by Braak and Braak.47 Striepens et al. 
reported reduced volumes of the right amygdala in subjective memory impairment.48 
Our uncorrected results are in accordance with this. However, contrary to previous 
studies, we did not find significant shape differences in the ventricular surface of the 
superior medial temporal horn after correction. 
 
Both uncorrected and corrected results showed asymmetric displacement of nodes on 
the ventricular surface. Asymmetry of hippocampal and amygdalar atrophy has been 
described in MCI, frontotemporal lobar degeneration (FTLD) and AD.8,49-51 In these 
studies, the structures in the left hemisphere were found to be smaller than in the right 
hemisphere. Dickerson et al. reported smaller left medial temporal lobe volumes 
compared to right medial temporal lobe volumes in non-demented patients and in 
patients with very mild AD.50 Barnes et al. compared patterns of hippocampal and 
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amygdalar atrophy between controls, persons with FTLD and persons with AD and 
consistently found hippocampal and amygdalar volumes to be smaller on the left side 
than on the right side, with asymmetry most pronounced in FTLD.49 Shi et al. conducted 
a meta-analysis and found that average volume reduction was stronger in the left 
hippocampus in both MCI and AD.51 Van der Flier et al. segmented the hippocampus in 
persons with subjective memory complaints and observed smaller left hippocampal 
volumes in patients with subjective memory complaints.8 Concurring with earlier 
reports on left to right asymmetry in cognitive impairment, we found that average 
displacement of the ventricular shape adjacent to the thalamus was larger on the left 
side than on the right side using local shape difference analysis. The causes for the 
observed left versus right asymmetry may be congenital in origin, or as a result of 
neurodegenerative processes that result in atrophy. 
 
The strengths of the present study include the clear classification of persons into two 
separate groups through an extensive neuropsychological test battery, as well as the 
use of a validated automated set-up of our local shape difference analysis method. The 
study is limited by the indirect assessment of atrophy in periventricular structures 
through shape differences of the bordering ventricular surface. Nevertheless, manual 
delineation of the periventricular structures for direct segmentation is limited by an 
inherent lack of macroscopic contrast of some periventricular structures, as well as an 
age-related decline of contrast. 
 
In conclusion, the present study demonstrates that the thalamus and the corona radiata 
may be involved in the pathological changes leading to subjective memory complaints. 
Uncorrected results show tentative evidence of a role for the corpus callosum, 
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Intracranial compartment volumes in 
normal pressure hydrocephalus:  
volumetric assessment versus outcome 
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Although enlargement of the cerebral ventricles plays a central role in the diagnosis of 
Normal Pressure Hydrocephalus (NPH), there are no reports on the use of volumetric 
assessment to distinguish between patients who respond to ventriculoperitoneal 
shunting and those who do not. The purpose of the present study is to explore the 
association between pre-operative intracranial compartment volumes and 
postoperative improvement. 
 
Twenty-six patients (17 men, mean age 75 years [range: 54 – 87 years]) with a clinical or 
radiological suspicion of NPH were included in the study. Gait, cognition and bladder 
function were evaluated by clinical rating. MR imaging of the brain was acquired at 0.5T 
and 1.5T. Total intracranial volume, ventricular volume, brain volume and pericerebral 
CSF volume were determined by volumetric assessment. Four imaging variables were 
determined: ventricular volume ratio, brain volume ratio, pericerebral CSF volume ratio 
and the ratio between ventricular volume and pericerebral CSF volume. All patients 
underwent ventriculoperitoneal shunting. 
 
Clinical follow-up was assessed one year after shunting. No difference in the mean 
ventricular volume ratio, the mean brain volume ratio, the mean pericerebral CSF 
volume ratio and the mean ratio between ventricular and pericerebral CSF volume was 
found between subjects who improved on gait or cognition or bladder function and 
those who did not. 
 
Volumetric assessment has no predictive value in differentiating between NPH patients 




Forty years ago, Adams et al. described a syndrome that combined a clinical triad of gait 
impairment, cognitive impairment and urinary incontinence with normal cerebrospinal 
fluid pressure.1 The clinical triad together with enlargement of the cerebral ventricles 
on Computed Tomography (CT) or Magnetic Resonance (MR) imaging is suggestive for 
the Normal Pressure Hydrocephalus (NPH) syndrome.2 The uniqueness of this syndrome 
lies in the partial reversibility of the symptoms after the insertion of a ventricular 
shunt.1 Despite high morbidity rates,3 and lack of evidence indicating that shunt 
placement is effective in the management of NPH,4 shunting remains the standard 
treatment.5 Many diagnostic procedures have been described that may increase the 
probability of selecting the appropriate candidates for shunting. Factors that predict a 
good surgical outcome are substantial improvement after one or several lumbar 
cerebrospinal fluid (CSF) taps,6-7 substantial improvement after continuous external 
lumbar CSF drainage,8-10 occurrence of B-waves more than 50% of the recording time 
during continuous intracranial pressure monitoring,11-15 resistance to CSF outflow of 18 
mm Hg/ml per minute or higher during continuous lumbar CSF infusion test,12,16 or the 
observation on MR imaging of increased CSF flow through the aqueduct.17-18 
 
Volumetric assessment of intracranial compartments has been used to distinguish NPH 
patients from healthy subjects and to set the syndrome apart from obstructive 
hydrocephalus, brain atrophy, cerebrovascular disease, vascular dementia or 
Alzheimer’s disease.19-25 Given the important role of enlargement of the cerebral 
ventricles in the diagnosis of NPH, a quantitative approach of ventricle size could be 
useful for the selection of patients for ventriculoperitoneal shunting. There are no 
previous reports on the use of volumetric assessment to distinguish between patients 
who respond to ventriculoperitoneal shunting and those who do not. 
 
In the present study, volumetric measurements were performed in patients with clinical 
NPH to study the association of preoperative intracranial compartment volumes with 
postoperative outcome. The preoperative ventricular volume, brain volume, 
pericerebral CSF volume, and the ratio between ventricular volume and pericerebral 
CSF volume were quantified and correlated with postoperative improvement in gait 




All patients with presumed NPH referred to our Department of Neurosurgery between 
1995 and 2001 were invited to participate. The diagnosis of NPH was made by 
independent neurologists from our hospital’s neurological department or neurological 
departments from surrounding regional hospitals. When the neurologist diagnosed 
NPH, both conservative and operative management possibilities were discussed with 
the patient. If the patient chose a surgical approach he was referred to the 
neurosurgeon. Of the 28 patients that fulfilled the criteria of presumed NPH, 26 
consented to participate in our study (17 males, mean age 75 years, median age 77 
years, range 54 to 87 years). Inclusion criteria were the following: wide based gait 
imbalance or small stepped shuffling gait, and dilated lateral and third ventricles in 
combination with a frontal horn index (the ratio between the maximal width of the 
frontal horns and the width of the whole brain at the same level)26 of 0.40 or higher.27 
Neither cognitive impairment nor bladder dysfunction was required for inclusion. 
Patients presenting with dementia of the Alzheimer’s type were excluded. Informed 
consent was obtained for all patients. 
Clinical examinations 
Gait and bladder function were evaluated by one of us, an experienced neurosurgeon 
(R.W.). Gait impairment was rated on a five point scale: (0) normal, (1) slight gait 
imbalance, (2) marked gait imbalance but not requiring aid, (3) walking not possible 
without a cane or the help of one person, (4) gait severely impaired, only possible with 
the aid of one person on each side, (5) total incapacity for standing or walking, even 
with help.27 Bladder function was registered as (0) normal, (1) increased bladder 
urgency, and (2) urinary incontinence. Cognitive function was assessed with an 
extensive neuropsychological test battery by one of us, an experienced clinical 
neuropsychologist (H.M.). 
MR image acquisition and processing 
MR brain imaging was performed in all patients prior to ventriculoperitoneal shunting. 
Dual spin-echo (proton density and T2 weighted) images were acquired at field 
strengths of 0.5T (n=7) or 1.5T (n=19) (Philips Medical Systems, Best, The Netherlands) 
with 2500 ms repetition time, 27/120 ms echo time, a 256 x 256 matrix and 6 mm slice 
thickness with 0.6 mm interslice gap, covering the whole brain. Locally developed semi-
automated segmentation software (SNIPER, Software for Neuro-Image Processing in 
Experimental Research) that combines knowledge-based fuzzy clustering and region-
growing techniques was used to process the images.28 The outer contour of the 
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subarachnoid space was manually delineated on each slice by one observer (W.P.), 
which was followed by an automated segmentation procedure that assigned brain 
tissue and CSF within this region (Figure 5.1). The volumetric assessment was repeated 
for five out of 26 subjects (19%) to analyze the intra-rater reliability. The intra-class 
correlation coefficient was larger than 0.99, indicating high intra-rater reliability. We 
determined total intracranial volume (TICV, comprising brain parenchyma and CSF), 
total brain volume (TBV), ventricular CSF volume (VV, comprising lateral, third and 
fourth ventricles) and extraventricular CSF volume (EVV, reflecting pericerebral CSF 
volume). Ventricular volume, brain volume and pericerebral CSF volume were 
converted into ratios from total intracranial volume to normalize for head size. 
Ventriculomegaly out of proportion to cortical sulcal enlargement, a neuro-imaging 
characteristic of NPH,18;29-31 was quantified by dividing ventricular volume by 
pericerebral CSF volume. In summary, four imaging variables were obtained: ventricular 
volume ratio, brain volume ratio, pericerebral CSF volume ratio and a ratio between 
ventricular and pericerebral CSF volume. 
 
Figure 5.1 
Intracranial semi-automated segmentation was based on axial T2 (A) and 
proton density weighted images. The outer contour of the subarachnoid 
space was manually delineated on each slice (B). This was followed by an 
automated segmentation procedure that assigned brain tissue and CSF 
within this region. We determined total intracranial volume, ventricular 
volume (C), brain volume and pericerebral CSF volume (D).  
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Ventriculoperitoneal shunting 
All patients underwent ventriculoperitoneal shunting. The type of shunt was a Codman-
Medos non-programmable valve system with an opening pressure of 100 mm H2O. The 
patency of the shunt was judged by a neurosurgeon through clinical examination at 2, 6, 
and 12 months after ventriculoperitoneal shunting. In patients with lack of amelioration 
or clinical deterioration in combination with lack of decrease of the ventricular volume 
on CT or MR imaging, a surgical drain revision was carried out. The subjects remained 
shunted during the entire follow-up period of one year after shunt placement. 
Statistical methods 
The mean ventricular volume ratio, the mean brain volume ratio, the mean pericerebral 
CSF volume ratio and the mean ratio between ventricular and pericerebral CSF volume 
were compared between the patients that improved after shunting and those who did 
not. Improvement of gait, improvement of cognition and improvement of bladder 
function were determined by clinical rating (R.W. and H.M. respectively). 27 Mann-
Whitney U tests were applied to assess differences between the four imaging variables 
and improvement in gait or cognition or bladder function (SPSS, version 11.5; SPSS Inc., 
Chicago, IL). Adjustments were made for multiple comparisons using the Bonferroni 
method. The level of statistical significance was set at p < 0.05. 
Results 
All 26 patients had gait impairment, 22 were cognitively impaired and 22 suffered from 
urinary incontinence. Clinical follow-up for the assessment of treatment effect took 
place one year after shunting. Three had died in the follow-up period and were 
excluded from our analysis. After shunting, 19 out of 23 remaining patients (83%) with 
preoperative gait impairment showed an improved walking pattern. Nine out of 19 
remaining patients (47%) with preoperative cognitive impairment showed improved 
cognition after shunting. Nine out of 20 remaining patients (45%) with preoperative 
bladder dysfunction reported a decrease in urinary urgency or urinary incontinence 
after shunting. 
 
Baseline values of total intracranial volume, ventricular volume, brain volume and 
extraventricular volume for all subjects are presented in Table 5.1. The mean and 
standard deviation of the four imaging variables are presented in Table 5.2, classified 




Table 5.1 Baseline MR imaging values 
 Mean (in cc) SD
Total intracranial volume 1533.98 133.32  
Ventricular volume 156.25 46.20 
Brain volume 1176.50 105.07 
Pericerebral CSF volume 201.23 37.89 
MR: Magnetic resonance, SD: Standard deviation, CSF: Cerebrospinal fluid 
 








Ventricular volume ratio 0.11 (± 0.01) 0.11 (± 0.03)  
Brain volume ratio 0.76 (± 0.02) 0.77 (± 0.03)  
Pericerebral CSF volume ratio 0.13 (± 0.02) 0.13 (± 0.02)  







Ventricular volume ratio 0.10 (± 0.03) 0.11 (± 0.02)  
Brain volume ratio 0.77 (± 0.03) 0.76 (± 0.02) 
Pericerebral CSF volume ratio 0.13 (± 0.02) 0.12 (± 0.02)  







Ventricular volume ratio 0.11 (± 0.03) 0.10 (± 0.02)  
Brain volume ratio 0.76 (± 0.03) 0.78 (± 0.02)  
Pericerebral CSF volume ratio 0.13 (± 0.02) 0.12 (± 0.01)  
Ratio between ventricular and pericerebral CSF volume 0.84 (± 0.29) 0.91 (± 0.25) 
Ventricular volume, brain volume and pericerebral CSF volume were converted into ratios from total 
intracranial volume to normalize for head size. CSF: Cerebrospinal Fluid 
 
The mean of the four imaging variables - ventricular volume ratio, brain volume ratio, 
pericerebral CSF volume ratio and ratio between ventricular volume and pericerebral 
CSF volume - did not differ significantly between patients who experienced 
improvement in gait after shunting and those who did not. No significant differences 
were found in the mean of the four imaging variables between patients who improved 
in cognition and those who maintained the same level of cognitive impairment. There 
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were also no significant differences in the mean of the four imaging variables between 
patients who did not report an improvement in bladder function and those who did 
experience less urinary urgency or urinary incontinence after shunting. 
Discussion 
Our most important finding is that the mean ventricular volume ratio, the mean brain 
volume ratio, the mean pericerebral CSF volume ratio nor the mean ratio between 
ventricular and pericerebral CSF volume were different between NPH patients who 
improved on gait or cognition or bladder function after ventriculoperitoneal shunting 
and those who did not. 
 
Our results suggest that volumetric assessment of intracranial compartments has no 
predictive value in differentiating between NPH patients who will respond favorably to 
ventriculoperitoneal shunting and those who will not. Volumetric assessment has 
previously been employed to set NPH apart from other conditions and healthy 
elderly.22-23 The technique has not been used to compare intracranial compartment 
volumes between NPH patients who improved after ventriculoperitoneal shunting and 
those who did not. In one study MR brain images were used to study the pre-operative 
neuro-imaging characteristics of NPH in relation to clinical outcome after 
ventriculoperitoneal shunting.32 In this study, CT and MR brain images were 
independently evaluated in a qualitative way by a neuroradiologist, showing an 
association between pre-operative cortical sulci size and post-operative improvement in 
gait, cognition and bladder function, whereas ventricular volume was unrelated to post-
operative outcome. The finding of an association between pre-operative cortical sulci 
size or pericerebral CSF volume and outcome was not reproduced in our study. 
 
A potential limitation of our study is that all the included subjects were patients eligible 
for shunting. This resulted in the lack of a control group and a moderate spread of 
values. Still, it should be realized that our population represents a consecutive clinical 
group eligible for shunting, which is the group that benefits most from pre-operative 
risk stratification. In addition, if ventricular volume stays the same after the shunt is 
placed, and the patient does not get better, then a shunt function study needs to be 
done to determine if the shunt is indeed functioning in light of the fact that the volume 
of the ventricles has not changed. 
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Conclusion 
The ventricular volume ratio, brain volume ratio, pericerebral CSF volume ratio nor the 
ratio between ventricular and pericerebral CSF volume were different between NPH 
patients who improved on gait or cognition or bladder function and those who did not. 
Volumetric assessment of intracranial compartments has no predictive value in 
differentiating between NPH patients who will respond favorably to 
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Normal Pressure Hydrocephalus is characterized by gait impairment, cognitive 
impairment and urinary incontinence, and is associated with disproportionate 
ventricular dilation. Here we report the distribution of ventricular volume relative to 
sulcal CSF volume, and the association of increasing ventricular volume relative to sulcal 
CSF volume with a cluster of gait impairment, cognitive impairment and urinary 
incontinence in a stroke-free cohort of elderly persons from the general population. 
 
Data are based on 858 persons (35.4 % men, age range 66-92 years) who participated in 
the Age, Gene/Environment Susceptibility Study - Reykjavik Study. Gait was evaluated 
with an assessment of gait speed. Composite scores representing speed of processing, 
memory and executive function were constructed from a neuropsychological battery. 
Bladder function was assessed with a questionnaire. MR brain imaging was followed by 
semi-automated segmentation of intracranial CSF volume. White matter hyperintensity 
(WMH) volume was assessed with a semi-quantitative scale. For the analysis of 
ventricular dilation relative to the sulcal spaces, ventricular volume was divided by 
sulcal CSF volume (VV/SV). 
 
Disproportion between ventricular and sulcal CSF volume, defined as the highest 
quartile of the VV/SV Z score, was associated with gait impairment (OR 1.9, 95% CI 1.1 – 
3.3), and cognitive impairment (OR 1.8, 95% CI 1.1 – 3.0). We did not find an association 
between the VV/SV Z-score and bladder dysfunction. 
 
The prevalence and severity of gait impairment and cognitive impairment increases 
with ventricular dilation in persons without stroke from the general population, 




Cerebral atrophy is a pathologic diagnosis indicating an irreversible loss of brain 
substance.1,2 It appears as progressive dilation of the ventricles and cortical sulci on 
Magnetic Resonance (MR) imaging.1 Global cerebral atrophy is often classified into sub-
cortical atrophy, reflecting ventricular dilation, and cortical atrophy, reflecting the 
dilation of cortical sulci.3 
 
Sub-cortical atrophy and cortical atrophy may not be in proportion with each other 
(Figure 6.1). When the amount of sub-cortical atrophy corresponds with the amount of 
cortical atrophy, this may be indicative of global cerebral atrophy, as seen with 
increasing age. However, when a disproportion between ventricular dilation and the 
dilation of sulcal CSF volume is noted (Figure 6.1), Normal Pressure Hydrocephalus 
(NPH) may be suggested, when these MRI findings are associated with gait impairment, 
cognitive and urinary urgency or incontinence.4-7 Suspicion of NPH is increased when 
gait imbalance predominates and when cognitive deficit is only slight, moderate, or 
even absent.8 When dementia is the most severe symptom, the probability of NPH is 
very low.9,10 Bladder dysfunction occurs only at later stages of NPH and is present in 
approximately 55 percent of patients with NPH.9,10 Thus, based on previous work, the 















In this example, the volume of the ventricles is out of 
proportion to the volume of the sulcal spaces. 
 
The different clinical components of the NPH triad are each highly prevalent in older 
persons. Gait disorders affect 20% to 50% of elderly persons.11,12 Prevalence studies of 
dementing illnesses suggest an overall prevalence rate of about 6% to 8% among 
individuals older than 65 years and a prevalence rate of over 30% among individuals 
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older than 85 years.13,14 The prevalence of at least some degree of bladder dysfunction 
is estimated at 11% to 31% of men aged 60 years and older15 and at 30% to 50% of 
elderly women.16 It is not known to what extent gait impairment, cognitive impairment 
and bladder dysfunction cluster together in the general population of older adults. 
Furthermore, patients with white matter hyperintensities (WMH) or subcortical 
arteriosclerotic encephalopathy often present with an enlarged ventricular system and 
symptoms and signs similar to those seen in NPH.17-19 
 
Here we report on the prevalence of clusters of gait impairment, cognitive impairment 
and bladder dysfunction and their association with ventricular dilation, independent of 
WMH volume. 
Methods 
Persons participating in this study were a sample of the Age, Gene/Environment 
Susceptibility (AGES) – Reykjavik Study; a population-based study initiated to examine 
the contribution of genetic susceptibility and gene/environment interaction to 
conditions common in old age. The AGES – Reykjavik Study is an extension of the 
Reykjavik Study (RS) (1967-1994), a prospective study of cardiovascular disease based 
on a cohort of men and women born 1907-1935 and living in Reykjavik at the time of 
baseline measure in 1967.20,21 All participants in the AGES - Reykjavik Study underwent 
extensive evaluation, including MRI of the brain, neuropsychological testing, physical 
performance, a standard clinical evaluation, and an in-person questionnaire. This report 
is based on those participants examined from September 2002 until March 2004 (n = 
2,300). The protocol was approved by the Icelandic National Bioethics Committee (VSN 
00-063), the Icelandic Data Protection Authority, and by the Institutional Review Board 
of the US National Institutes of Health.22 
Measurement of gait 
Gait was evaluated as the time in seconds needed to walk 6 meters. There were two 
measurements at usual pace and separately two at quick pace.23-25 The two 
measurements for usual pace and quick pace were averaged separately for one 
estimate of normal gait and one for fast gait. Since there are no standardized cut-points 
for impaired gait speed in the 6-meter walk test, the upper quartile in either normal or 
fast gait was defined as gait impairment, similar to previous studies.26,27 
61 
Measurement of cognitive function 
Composite scores of executive function, memory and speed of processing were 
constructed from a battery of neuropsychological tests. The fit of these theoretical 
composites has been described in a previous publication.28 The executive function 
composite consisted of: the Digits Backward,29 the CANTAB spatial working memory 
task,30 and the Stroop Test Part III31. The memory composite consisted of: California 
Verbal Learning Test immediate and delayed recall.32 The speed of processing 
composite consisted of: the Digit Symbol Substitution Test,29 Figure Comparison,33 and 
the Stroop Test Parts I and II.31 All tests were normally distributed, thus composite 
measures were computed by averaging z-scores. A diagnosis of dementia - established 
in a multidisciplinary consensus meeting - was used to control for the possibility that 
cognitive impairment was partly due to comorbidities, such as Alzheimer’s Disease. 
Measurement of bladder function 
Bladder function was assessed with a standard questionnaire. Dysfunction, when 
present, was characterized into (1) urinary incontinence associated with an activity like 
coughing, lifting, standing up or exercise (2) urge incontinence where the subject 
cannot get to the toilet fast enough and (3) urinary incontinence unrelated to coughing, 
sneezing, lifting or urge. Normal Pressure Hydrocephalus (NPH) type bladder 
dysfunction was defined as positive answers to questions 2 or 3, corresponding with 
descriptions in literature.4,10,34 
MR image acquisition and post-processing 
The current analyses required dual fast spin-echo (proton density (PD) and T2-
weighted) and Fluid-Attenuated Inversion Recovery (FLAIR) images, which were 
acquired at a field strength of 1.5T (GE Medical Systems, Milwaukee, Wisconsin). The 
PD- and T2-weighted scans were performed with a field of view of 220 mm, a 256 x 256 
matrix size, section thickness of 3.0 mm and no slice gap. The FLAIR scans were 
performed with a field of view of 220 mm, a 256 x 256 matrix size, section thickness of 
3.0 mm and no slice gap. 
 
Cerebral infarcts were defined as lesions 4 mm or larger in the maximum diameter over 
a vascular distribution with typical MRI characteristics (e.g. a signal intensity that was 
isointense to that of cerebrospinal fluid), and were distinguished from WMHs. 
Cerebellar infarcts had no size criteria since lesions in this area can be very small. A 
neuroradiologist first examined the images for presence of cortical, subcortical, and 
cerebellar infarcts. Then, radiographers characterized the infarcts in more detail. WMH 
volume was assessed with a semi-quantitative scale with known reliability and validity.35 
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To analyze the scans we used previously described automated segmentation software 
(SNIPER, Software for Neuro-Image Processing in Experimental Research) that combines 
knowledge-based fuzzy clustering and region-growing techniques.35 The dual fast spin-
echo and FLAIR images were co-registered using FMRIB’s Linear Imaging Regression 
Tool (FLIRT)36 prior to processing by SNIPER. Brain extraction was followed by an 
automated segmentation procedure that assigned CSF within the cranium. CSF 
belonging to the lateral and third ventricles was manually labeled as ventricular volume 
by an experienced reader (W.M.P.). The volumetric assessment was repeated for 43 out 
of 834 persons (5%) to analyze the intra-rater reliability in our sample. The assessment 
yielded an intra-class correlation coefficient greater than 0.99, indicating high intra-
rater reliability. The program estimated ventricular volume (VV), sulcal CSF volume (SV), 
total brain volume (TBV) and total intracranial volume (TICV). To express ventricular 
dilation relative to the volume of the sulcal spaces, ventricular volume was divided by 











Figure 6.2 Volumetric assessment using SNIPER 
Intracranial semi-automated segmentation was based on 
dual spin-echo (proton attenuation and T2-weighted) and 
Fluid-Attenuated Inversion Recovery (FLAIR) images. With 
SNIPER we estimated ventricular volume (VV), sulcal CSF 
volume (SV), total brain volume (TBV) and total intracranial 
volume (TICV). TBV/TICV was used as a measure of 
corrected brain volume.  
Covariates 
Based on previous studies, we adjusted for a number of potentially confounding 
demographic and health history factors. Education (primary, secondary, college and 
university), and smoking status (categorized in this analysis as current or previous 
smoker versus non-smoker) were assessed with a questionnaire.37,38 The presence of 
depressive symptoms were assessed using the fifteen-item, shortened version of the 
Geriatric Depression Scale-Shortened (GDSS);39 a score of 6 or greater was classified as 
high depressive symptomatology.40 We adjusted for cardiovascular risk factors and 
disease as they are reported to be associated with gait and cognition.41,42 Systolic and 
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diastolic blood pressures, measured in supine position, were defined as the first and 
fifth Korotkoff sounds respectively. History of hypertension was defined as the use of 
antihypertensive medication, self-reported physician’s diagnosis of hypertension, or a 
systolic blood pressure equal to or higher than 140 mm Hg or a diastolic blood pressure 
equal to or higher than 90 mm Hg. History of coronary heart disease and peripheral 
arterial disease (intermittent claudication) were assessed with a questionnaire. Diabetes 
was defined as a self-reported physician’s diagnosis of diabetes, the use of diabetic 
medications (glucose lowering medications and insulin), which was noted from 
medication vials brought to the clinic or a fasting blood glucose level ≥ 7.0 mmol/l 
(equivalent to a fasting blood glucose level of 126 mg/dL, defined as diabetes by the 
American Diabetes Association). Body mass index was calculated from measured height 
and weight. 
Analytical sample 
Of the first 2300 participants, 435 were excluded because no or incomplete MRI images 
were acquired. The reasons for this were: only participation in a home visit, contra-
indications for MRI (such as a pacemaker, ocular foreign body or artificial heart valve), 
claustrophobia or equipment failure. Of the remaining 1865 participants, 697 persons 
were excluded because of the presence of infarcts (parenchymal defects 4 mm or 
larger, including Virchow-Robin spaces, and cerebellar infarcts), acute hematomas or 
mass occupying lesions. The exclusion for the presence of infarcts was based on two 
reasons. Infarcts may be associated with gait or cognitive impairment as well as bladder 
dysfunction. Furthermore, infarcts cause an overestimation of sulcal CSF volume. An 
additional 310 persons were excluded due to failed MR image pre- and post-processing 
with the SNIPER program, leaving a final sample of 858 persons with complete MRI 
post-processed data. Compared to those with complete MRI post-processing data, the 
group of excluded persons was older and contained a higher percentage of men and 
persons with coronary heart disease, diabetes mellitus and cognitive impairment in 
either executive function, memory or speed of processing), all significantly different at p 
< 0.05, adjusted for age and sex. There was no significant difference in education, 
smoking status, BMI, depressive symptomatology, hypertension, bladder dysfunction or 
gait speed between the included and excluded persons. 
Statistical analysis 
The higher the value of VV/SV, the more the disproportion between ventricular and 
sulcal CSF volume. The VV/SV was transformed into standard deviation units (the VV/SV 
Z-score) and divided into quartiles; the first quartile of the VV/SV Z-score, i.e. the group 
with the least disproportion, served as the reference group. To discriminate persons 
with a low performance in the gait test, persons were divided into quartiles of the gait 
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variables. The upper quartile in either normal or fast gait was defined as gait 
impairment. The lowest quartile of each of the cognitive composites was classified as 
impairment in that ability. Impairment in either executive function, memory or speed of 
processing was classified as cognitive impairment. Bladder dysfunction was classified as 
urinary urgency or incontinence unrelated to coughing, sneezing, lifting or urge. 
 
We used logistic regressions to examine the association of the VV/SV Z-score to gait 
impairment, cognitive impairment and bladder dysfunction. We also examined the 
association of combinations of overall gait impairment, cognitive impairment and 
bladder dysfunction to quartiles of the VV/SV Z-score. Two models were tested; the first 
model adjusted for age and sex; the second model had additional adjustments for 
education, smoking status, body mass index, depressive symptomatology, coronary 
heart disease, hypertension, diabetes mellitus, peripheral arterial disease, white matter 
hyperintensity volume and corrected brain volume (SPSS, version 11.5; SPSS Inc., 
Chicago, IL). 
Results 
The mean, raw VV/SV for the entire population of 858 was 0.16 (standard deviation: 
0.07, range: 0.04 - 0.71). The distribution of VV/SV is presented in Figure 6.3, with 
image examples from each of the four quartiles in Figure 6.4. Persons in the lowest 
quartile of VV/SV Z-score are younger and consist of relatively fewer men, but 














Figure 6.3 Distribution of VV/SV 
 This histogram shows the distribution of VV/SV in 
our study population. The vertical lines indicate 
borders between quartiles.  
65 
 
Figure 6.4 Examples of MRI images 
Examples of MRI images for persons in the first, second, third and 
fourth quartile of the VV/SV Z-score.  
 
Table 6.1 Participant characteristics by quartile of the VV/SV Z-score: AGES-Reykjavik Study 
 Quartiles of the VV/SV Z-score 
 1 
(n = 214) 
2 
(n = 215) 
3 
(n = 215) 
4 
(n = 214) 
Age, mean, y (Std) 73.4 (5.0) 74.8 (5.1) 75.4 (5.4) 76.4 (5.5) 
Men, % 27 37 37 42 
Education, % only primary education 22 22 22 22 
Ever smokers, % 60 61 61 58 
Body Mass Index, mean (Std) 27.5 (4.4) 26.5 (3.9) 27.4 (4.6) 26.3 (4.5) 
Depression symptomatology, %  4  7  6  6 
History of coronary heart disease, % 18 24 16 18 
Hypertension, % 69 68 64 67 
Diabetes mellitus, %  7  7  9  8 
Peripheral arterial disease, %  4  4  5  3 
Compared to the lowest quartile, those in the top three quartiles were older and more likely to be male. 
Depression symptomatology is defined as GDSS score of 6 and over. There are no significant trends across 
quartiles after adjustment for age and sex. 
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Of the 858 persons, 16.1 percent had both gait impairment and cognitive impairment, 7 
percent had both gait impairment and bladder dysfunction, 7 percent had both 
cognitive impairment and bladder dysfunction, and 4 percent had the complete cluster 
of symptoms that, as well as in other diseases, typically appear combined in NPH. For all 
except the bladder dysfunction, the prevalence of impaired individuals increased with 
increasing quartile of VV/SV (Table 6.2). 
 
Mean scores for each of the individual cognitive tests by quartile of the VV/SV ratio are 
presented in Table 6.3. Trend tests (p = 0.05) show that normal gait speed, fast gait 
speed, CANTAB Spatial Working Memory, Stroop 3, Immediate Recall, Delayed Recall, 
DSST, Figure Comparison, Stroop 1 and Stroop 2 show a greater impairment with 
increasing VV/SV ratio. Table 6.3 also shows the prevalence of dementia for each 
quartile of the Z-score VV/SV ratio. The prevalence of dementia moderately increases 
with an increase of the VV/SV ratio. 
 
Compared to the lowest quartile, the highest quartile of the VV/SV Z-score, was 
associated with overall gait impairment (OR 1.9, 95% CI 1.1 – 3.3; Model 2; Table 6.4). 
The trend of increasing overall gait impairment with increasing VV/SV Z-score was 
significant (p = 0.04; Model 2; Table 6.4). Compared to the lowest quartile, the highest 
quartile of the VV/SV Z-score was associated with cognitive impairment (OR 1.8, 95% CI 
1.1 – 3.0; Model 2; Table 6.4), but not a specific type of cognitive function. In addition, 
there was a significant trend of increasing cognitive impairment with increasing VV/SV 
Z-score (p = 0.008; Model 2; Table 6.4). There was an association of bladder dysfunction 
to the second quartile of VV/SV Z-score; but there was no trend across quartiles (Table 
6.4). 
 
Compared to the lowest quartile, the highest quartile of the VV/SV Z-score was 
associated with a combination of gait impairment and cognitive impairment (OR 2.6, 
95% CI 1.3 – 5.3; Model 2; Table 6.5). There was a significant trend for a combination of 
gait impairment and cognitive impairment with increasing VV/SV Z-score (p = 0.006; 
Model 2; Table 6.5). 
 
In general, having a combination of bladder dysfunction with either gait impairment or 
cognitive impairment was not associated with increasing quartiles of VV/SV Z-score 
(Table 6.5). Compared to the lowest quartile, only the third quartile of the VV/SV Z-
score was significantly associated with the triad of gait impairment, cognitive 
impairment and bladder dysfunction (OR 4.9, 95% CI 1.4 – 18.0). There was a modest 
trend (p = 0.07; Model 2; Table 6.5) of more persons with the complete cluster of 
symptoms with a higher VV/SV index. 
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Table 6.2 Percent distribution of impaired cases by quartile of VV/SV Z-score: AGES-Reykjavik Study 
 Quartiles of the VV/SV Z-score 
 1 2 3 4 
Mean VV/SV score 0.09 0.12 0.16 0.26 
Mean VV/SV Z-score 1.2 1.7 2.3 3.6 
Gait impairment 40 (19%)* 51 (24%)* 55 (26%)* 77 (37%)* 
Executive function impairment 27 (13%) 43 (21%) 47 (23%) 51 (26%) 
Memory impairment 27 (14%) 32 (16%) 42 (22%) 51 (28%) 
Speed of processing impairment 26 (13%)* 31 (15%)* 45 (21%)* 49 (25%)* 
Cognitive impairment 58 (30%)* 70 (36%)* 86 (45%)* 101 (52%)* 
Bladder dysfunction 40 (19%) 42 (20%) 59 (28%) 40 (19%) 
Gait impairment and cognitive impairment 18 (9%)* 29 (14%)* 39 (19%)* 48 (24%)* 
Gait impairment and bladder dysfunction  9 (4%) 11 (5%) 28 (13%) 14 (7%) 
Cognitive impairment and bladder dysfunction 11 (5%)  9 (4%) 26 (13%) 17 (8%) 
Triad  4 (2%)  4 (2%) 20 (10%) 9 (4%) 
Percentages in brackets represent the percentage of the included sample (n = 858). *Significant trend across 
quartiles after adjustment for age and sex (P < 0.05). 
 
Table 6.3 Sample characteristics of individual gait and cognitive tests according to quartiles of the VV/SV Z-
score 
 Quartiles of the VV/SV Z-score  
 1 2 3 4  
 Mean SD Mean SD Mean SD Mean SD Ptrend 
Gait speed* (time in s)   
Normal† -0.30 0.67 -0.21 0.64 -0.16 0.78 0.12 1.00 < 0.001 
Fast† -0.23 0.83 -0.14 0.85 -0.16 0.92 0.08 1.03 0.002 
Executive function*   
Digits backward 0.23 0.99 0.04 0.98 0.09 1.04 0.02 1.08 0.060 
Spatial Working Memory† -0.26 0.89 -0.11 1.02 0.10 0.90 0.02 0.96 < 0.001 
Stroop 3† -0.26 0.76 -0.09 0.95 -0.05 1.02 0.01 0.96 0.003 
Memory*   
Immediate recall 0.40 0.97 0.14 0.96 0.06 1.00 -0.10 0.95 < 0.001 
Delayed recall 0.39 0.98 0.15 0.98 0.11 0.97 -0.14 0.98 < 0.001 
Speed of processing*   
DSST 0.41 0.91 0.25 1.00 0.11 0.98 0.01 1.02 < 0.001 
Figure comparison 0.37 0.91 0.20 1.04 0.11 1.00 -0.06 1.00 < 0.001 
Stroop 1† -0.23 0.79 -0.12 1.01 -0.12 0.77 -0.05 0.74 0.037 
Stroop 2† -0.27 0.77 -0.14 1.01 -0.08 0.80 -0.02 0.88 0.002 
Dementia (%) 0.47 3.26 3.72 3.27  
*Z-scores (mean for total sample =0.0, standard devia on for total sample = 1.0); †Lower scores represent 
better performance. 
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Table 6.4 Quartiles of the VV/SV Z-score and individual impairments: AGES-Reykjavik Study 
 Model 1 
Quartiles of the VV/SV Z-score 
Model 2
Quartiles of the VV/SV Z-score 
 1 2 3 4 Ptrend 1 2 3 4 Ptrend  














































































The first quartile of the VV/SV Z-score, indicated in the table as 1.0, served as the reference group. Model 1 
was adjusted for age and sex. Model 2, the fully adjusted model, was adjusted for age, sex, education, 
smoking, body mass index, depression, hypertension, coronary heart disease, DM, total WMH volume, history 
of peripheral artery disease and brain volume corrected for intracranial volume. 
 *Indicates a significant relationship (P < 0.05). 
 
Table 6.5 Quartiles of the VV/SV Z-score and impairment combinations: AGES-Reykjavik Study 
 Model 1 
Quartiles of the VV/SV Z-score 
Model 2
Quartiles of the VV/SV Z-score 
 1 2 3 4 Ptrend 1 2 3 4 Ptrend  


























































The first quartile of the VV/SV Z-score, indicated in the table as 1.0, served as the reference group. Model 1 
was adjusted for age and sex. Model 2, the fully adjusted model, was adjusted for age, sex, education, 
smoking, body mass index, depression, hypertension, coronary heart disease, DM, total WMH volume, history 
of peripheral artery disease and brain volume corrected for total intracranial volume.  
*Indicates a significant relationship (P < 0.05). 
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Discussion 
This study examined the association of ventricular dilation relative to sulcal CSF volume 
with gait, cognitive function and bladder dysfunction in infarct-free older persons from 
a population-based sample. We found that those in the highest quartile of the VV/SV Z-
score, reflecting ventricular dilation, were more likely to have impaired gait and 
cognition. Those in the highest quartile of the VV/SV Z-score were also more likely to 
have both impaired gait and impaired cognition. There was no direct relationship 
between ventricular dilation and bladder dysfunction. The combination of gait 
impairment, cognitive impairment and bladder dysfunction, the three symptoms that 
typically appear combined in NPH, was present in 4.4 percent of our study sample. 
Presence of the complete cluster of symptoms was moderately more frequent as the 
quartile of VV/SV Z-score increased. These effects were present after adjustment for 
brain volume corrected for total intracranial volume. All associations were independent 
of WMH volume, and no differences were found in the prevalence of cardiovascular risk 
factors between the different quartiles of VV/SV Z-scores. 
 
This study is based on a well-characterized population-based cohort of men and women 
originally identified in the Reykjavik Study and who participated in the follow-up, the 
AGES – Reykjavik Study; they were not recruited into the study based on any particular 
characteristic, such as gait or cognitive impairment. Further, we had a standardized 
neuropsychological test battery of key cognitive functions and an automatic and highly 
reproducible segmentation of intracranial CSF volumes. However, it is noted this 
analytical sample excludes those who were older, more frequently male and who had 
cerebral infarcts on MRI, potentially limiting the generalizability of our study sample. 
NPH associated bladder dysfunction is described as urinary urgency or complete 
disinhibition of bladder function. Previous studies have employed many different 
questionnaires to classify the NPH type of bladder dysfunction, with the number of 
questions ranging between 2 and 18. However, an international group of experts 
recommended the use of a self administered three question incontinence questionnaire 
(3IQ) with questions similar to ours.43 Our assessment of bladder dysfunction captured 
a defined set of symptoms similar to those recommended; it is possible that questions 
on additional symptoms may identify a different group than was identified here. 
 
The association between ventricular dilation and gait impairment was known to exist in 
persons with NPH, and was also found in our study. In the pathogenesis of NPH, the 
mechanism by which distended ventricles affect gait, cognition and bladder function is 
unclear.44 One theory is that pressure effects of the distended ventricles are exerted on 
critical cerebral sites.44 The fibers of the corticospinal tract that supply motor function 
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to the legs pass closest to the lateral ventricles in the corona radiata, which may explain 
why gait disturbance is usually the first and leading symptom to appear in NPH.4,9,45 Of 
the three impairments, the association between ventricular dilation and gait 
impairment was the strongest in our study population, consistent with the NPH 
syndrome. 
 
We also found an association between ventricular dilation and cognitive impairment. 
Cognitive impairment is usually the second symptom to appear in NPH, and does not 
occur in all patients with NPH.9,10 When there is impairment, the cognitive deficit 
consists principally of memory impairment, decreased speed of complex information 
processing or poor executive function.4,10,46 While we did not find an association 
between ventricular dilation and impairment in a specific cognitive ability, ventricular 
dilation was associated with each of the functions we measured. 
 
We did not find an individual association between the VV/SV Z-score and bladder 
dysfunction. However, participants in the third quartile of the VV/SV Z score were more 
likely to have both gait impairment and bladder dysfunction. This may be due to an 
uneven distribution of persons with both gait impairment and bladder dysfunction 
among the quartiles (Table 6.2). In addition, it may be possible that persons in the 
highest quartile of the VV/SV Z-score had difficulties reporting bladder dysfunction due 
to cognitive impairment. Bladder dysfunction has been described as a late stage 
symptom in NPH,10 suggesting it would only be associated with VV/SV Z-score when 
both gait impairment and cognitive impairment are present. 
 
The exact incidence and prevalence of NPH in the general population is not known.9 
This is partly explained by inconsistent definitions of NPH, which rely on clinical and 
neuroimaging criteria in some series, and is confirmed by improvement after ventricular 
shunting in others.10 We found a 4.4 percent prevalence of a combination of gait 
impairment, cognitive impairment and bladder dysfunction. This number is limited by 
the inability to control for other causes of gait impairment, such as lumbar canal 
stenosis, or other causes of bladder dysfunction.8 
 
In conclusion, in our population-based sample of infarct-free men and women, 
ventricular dilation, the radiological hallmark of NPH, can be observed frequently and, 
similar to NPH, this phenomenon is associated with cognitive and gait impairment, and 
sometimes bladder dysfunction. Whether and how often symptomatic individuals with 
ventricular dilation from the general population could benefit from ventricular shunting 
remains to be determined. The quantitative measure of ventricular dilation presented in 
this study would be a useful tool for future studies addressing this question. 
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Ventricular dilatation out of proportion to the sulcal cerebrospinal fluid (CSF) volume is 
a characteristic of normal pressure hydrocephalus (NPH), but has also been described in 
the general population. We hypothesized that disproportionate ventricular dilatation 
could be caused by atrophy of the white matter based on small vessel disease. Our aim 
was to investigate the relationship between white matter hyperintensity (WMH) volume 
and disproportionate ventricular dilatation. 
 
Data are based on 858 persons (35.4 % men, age range 66-92 years) who participated in 
the Age, Gene/Environment Susceptibility Study - Reykjavik Study. MRI was followed by 
segmentation of ventricular, sulcal and WMH volume. Disproportionate ventricular 
dilatation was measured using the ratio of ventricular volume and sulcal CSF volume, 
VV/SV. Linear regressions were used to study the relationship between WMH volume, 
ventricular volume, sulcal CSF volume, and VV/SV, adjusted by age, sex, smoking, 
hypertension, cardiac disease, blood cholesterol, diabetes, body mass index and total 
intracranial volume. 
 
WMH volume was positively correlated with ventricular volume and VV/SV (both at p < 
0.001). However, WMH volume showed a negative correlation with sulcal CSF volume 
(p < 0.001). 
 
Our findings suggest that dilatation of the ventricles in patients with white matter 
hyperintensities may not be a mere reflection of small vessel disease based atrophy, but 
that it could be, at least partly, based on active expansion of the ventricles. This 




Disproportionate ventricular dilatation is the radiological hallmark of normal pressure 
hydrocephalus (NPH), a syndrome characterized by a relative increase in ventricular 
volume and impairment of gait, cognition and sometimes bladder function.1-3 In a 
population-based study, it was demonstrated that this radiological phenomenon is 
often observed in the elderly and that it is associated with subclinical impairment.4 
 
The cause of disproportionate ventricular dilatation is not known. However, patients 
with WMH often present with an enlarged ventricular system, as well as symptoms and 
signs similar to those seen in NPH.5-7 Furthermore, there is firm evidence that WMH in 
the elderly are based on cerebral small vessel disease (SVD).8 Based on these 
observations, we hypothesized that disproportionate ventricular dilatation is the 
consequence of selective central atrophy secondary to SVD. Since WMH are one of the 
main manifestations of SVD, we predicted that WMH would be associated with 
disproportionate ventricular dilatation. 
Materials and methods 
Patients 
Subjects are participants in the Age, Gene/Environment Susceptibility (AGES) Reykjavik 
Study; a population study initiated to examine the contribution of genetic susceptibility 
and gene/environment interaction to phenotypes common in old age. The AGES is an 
extension of the Reykjavik Study (1967-1994); a prospective study of cardiovascular 
disease based on a cohort of men and women born 1907-1935 and living in Reykjavik at 
the time of baseline measure in 1967. All participants in the AGES Study underwent 
extensive evaluation, including MRI of the brain, neuropsychological testing, physical 
performance, a standard clinical evaluation, and an in-person questionnaire. This report 
is based on those participants examined from September 2002 until March 2004 (n = 
2,300). The AGES Study was approved by the Icelandic National Bioethics Committee 
(VSN 00-063), the Icelandic Data Protection Authority, and by the institutional review 
board of the US National Institutes of Health.9 All participants gave written informed 
consent. 
MR image acquisition and post-processing 
The MRI acquisition protocol and post-processing has been described in an earlier 
study.4 The analyses required dual spin-echo (proton attenuation and T2-weighted) and 
Fluid-Attenuated Inversion Recovery (FLAIR) images, which were acquired at a field 
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strength of 1.5T (GE Medical Systems, Milwaukee, Wisconsin). The dual spin-echo scans 
were performed with a field of view of 220 mm, a 256 x 256 matrix size, section 
thickness of 3.0 mm, 54 slices and no slice gap. The FLAIR scans were performed with a 
field of view of 220 mm, a 256 x 256 matrix size, section thickness of 3.0 mm, 46 slices 
and no slice gap. All images were checked for cerebral infarcts by an experienced 
neuroradiologist. WMH segmentation was performed using a validated automatic 
image analysis pipeline. The algorithm consisted of a multi-spectral tissue classification, 
that has been described in detail in a previous publication.10 Areas with increased signal 
on proton attenuation, T2-weighted and FLAIR images were identified as WMH. 
 
To segment CSF volumes, we used previously described semi-automated segmentation 
software (SNIPER, Software for Neuro-Image Processing in Experimental Research) that 
combines knowledge-based fuzzy clustering and region-growing techniques.11 Brain 
extraction was followed by an automated segmentation procedure that assigned CSF 
volumes within the skull. CSF belonging to the lateral and third ventricles was manually 
labeled as ventricular volume. The fourth ventricle was not included in our analysis. The 
volumetric assessment was repeated for 43 out of 834 subjects (5%) to analyze the 
intra-rater reliability in our sample. The assessment yielded an intra-class correlation 
coefficient greater than 0.99, indicating high intra-rater reliability. The program 
estimated total intracranial volume and total CSF (tCSF) volume. Sulcal CSF volume (SV) 
was calculated by extracting ventricular CSF volume (VV) from tCSF volume. Ventricular 
dilatation was expressed as VV/SV. These volumetric measures have been applied in a 
previous publication.4 
Covariates 
Based on previous studies, we adjusted for possibly confounding demographic (age and 
sex) and health history factors. Systolic and diastolic blood pressures, measured in 
supine position, were defined as the first and fifth Korotkoff sounds respectively. 
History of hypertension was defined as the use of antihypertensive medication or a 
systolic blood pressure equal to or higher than 140 mm Hg or a diastolic blood pressure 
equal to or higher than 90 mm Hg. History of coronary heart disease, diabetes mellitus 
and peripheral arterial disease were assessed with a combination of questionnaire and 
clinical data, including medication use. Smoking status (current or previous smoker 
versus non-smoker) and body mass index calculated from measured weight and height 
were also included as covariates. 
Analytical sample 
Of the first 2300 participants, 1988 had MRI scans (312 were only examined at home or 
had contraindications for MRI). Of these 1988, a total of 433 participants were excluded 
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due to an incomplete MRI scan, an MRI scan of suboptimal image quality precluding 
successful image post-processing, or automated image post-processing failures. Finally, 
to avoid a possible overestimation of sulcal CSF volume in the automated segmentation 
procedure that assigned CSF volumes within the skull, we excluded 697 subjects with 
significant cerebral or cerebellar infarcts, defined as parenchymal defects with a long 
axis diameter ≥ 4mm outside the basal ganglia, the midbrain or the cortex along the 
path of the medullary arteries, and with a short axis diameter ≥ 4mm within these 
areas. This resulted in a sample of 858 subjects with complete MRI post-processed data. 
Compared to those with complete MRI post-processing data, the group of excluded 
subjects was older and contained a higher percentage of males and subjects with 
depressive symptomology, coronary heart disease and diabetes mellitus (all significantly 
different at p < 0.05, adjusted for age and sex). 
Statistical analysis 
A linear regression analysis was used to study the relationship between WMH volume 
and ventricular dilatation, adjusted for age, sex, smoking, hypertension, coronary heart 
disease, diabetes and body mass index (IBM SPSS Statistics, version 20; IBM Corp., 
Armonk, N.Y.). In addition, linear regression analyses were used to study the 
relationship between WMH volume and ventricular or sulcal CSF volume, adjusted for 
total intracranial volume, as well as adjusted for age, sex, smoking, hypertension, 
coronary heart disease, diabetes and body mass index. 
Results 
Our study population of 858 persons ranged in age from 66 to 92 years of age, and had 
a wide variety of cardiovascular risk factors (Table 7.1). Volumetric assessment yielded a 
mean total intracranial volume of 1738.5 ml, a mean VV of 43.1 ml, a mean sulcal CSF 
volume of 279.6 ml, and a median WMH volume of 12.3 ml. 
 
The associations between WMH volume, intracranial CSF compartments and 
disproportionate ventricular dilation are summarized in Table 7.2. WMH volume 
showed a significant positive association with VV, as well as with VV/SV, independent of 
demographic and cardiovascular risk factors and intracranial volume (both associations 
at p < 0.001, standardized coefficient beta 0.14 and 0.22 respectively). These findings 
indicate that increasing WMH was associated with both increasing ventricular volume 
and increasing disproportionate ventricular dilatation. WMH volume showed a 
significant negative association with SV, independent of demographic and 
cardiovascular risk factors and intracranial volume (p < 0.001, standardized coefficient 
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beta – 0.12). These findings indicate that increasing WMH was associated with 
decreasing sulcal CSF volume. In our adjusted model, none of the individual 
cardiovascular risk factors showed an independent association with VV/SV. 
 
Table 7.1 Participant characteristics 
 n = 858
Age, mean (SD) 75.0 (5.4)
Women (%) 64.6
Current or previous smoker (%) 60.0
Body mass index (SD) 26.9 (4.4)
Coronary heart disease (%) 18.8
Hypertension (%) 67.0
Diabetes mellitus (%) 7.7
Total intracranial volume, mean (ml) 1738.5
Ventricular volume, mean (ml) 43.1
Sulcal CSF volume, mean (ml) 279.6
WMH volume, median (ml) 12.3
 
Table 7.2 Association between WMH volume, intracranial CSF compartments and disproportionate ventricular 
dilation 
 Beta (95% CI) 
Ventricular volume 0.20 (5.09 – 9.48) 
Sulcal CSF volume -0.12 (-16.1 – -7.1) 
Ventricular volume / sulcal CSF volume 0.28 (0.03 – 0.04) 
After adjusting for age, sex, smoking, body mass index, blood cholesterol, coronary heart disease, 
hypertension, diabetes mellitus and intracranial volume, WMH volume shows a positive association with 
ventricular volume and disproportionate ventricular dilation, but a negative association with sulcal CSF 
volume. 
Discussion 
We observed that WMH volume has a positive association with both ventricular volume 
and disproportionate ventricular dilation, but a negative association with sulcal CSF 
volume. In the present study none of the cardiovascular risk factors (smoking, 
hypertension, body mass index, coronary heart disease and diabetes mellitus) showed 
an independent association with VV/SV, or disproportionate ventricular dilatation. 
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The association between WMH and ventricular dilatation has been extensively studied. 
A meta-analysis of 48 studies found a significant relation in the majority of studies, but 
did not find sufficient evidence to indicate that this relation is independent of shared 
risk factors, including vascular risk factors and age.12 Subcortical arteriosclerotic 
encephalopathy (SAE) - a form of small vessel vascular dementia caused by damage to 
the white matter13 - and NPH share a number of characteristics. Ventricular dilatation 
and an increased WMH load have been described in SAE,5-7 as well as in NPH.14,15Arterial 
hypertension is found in the majority of patients with SAE,16 and SAE has been 
associated with stroke and diabetes.17 While we did not find an independent association 
of cardiovascular risk factors with disproportionate ventricular dilatation in the present 
study, others observed an association between a clinical diagnosis of NPH and arterial 
hypertension, cardiac disease, peripheral vascular disease, and ischemia in the deep 
white matter.18-20 Furthermore, autopsy studies revealed that the vast majority of WMH 
in older persons are based on small vessel disease (SVD).21 We hypothesized that 
widening of the ventricles in the elderly is caused by selective SVD-induced atrophy of 
the periventricular white matter. The correlation between WMH load and ventricular 
dilatation that we observed was in line with our hypothesis. 
 
However, in addition to the association between increasing WMH and increasing 
ventricular volume, we also observed an association between increased WMH load and 
decreased sulcal CSF volume. This finding was unexpected, since in the case of mere 
parenchymal loss, the cortical sulci would be expected to widen as well, or, in case the 
atrophy would be selectively periventricular, stay the same. The increased volume of 
the ventricles and decreased volume of the sulcal CSF space that we found to be 
associated with WMH load suggests that the observed ventricular volume increase 
results from an outward displacement of the brain by expanding ventricles rather than 
from mere atrophy. This observation sheds new light on the pathophysiology of NPH. 
 
NPH is associated with increased cerebral capillary pulsations,22 and this association 
could provide an explanation for the relation we observed between expansion of the 
ventricles and WMH load. The origin of increased capillary pulsations in NPH may be the 
consequence of systemic arterial disease. Mitchell et al. demonstrated that increased 
stiffening of the aorta, assessed by pulse wave velocity measurements, gives rise to 
increased propagation of pulsatile energy into the vascular bed of end organs such as 
kidneys and brain.23 In addition, they demonstrated that in the elderly increased aortic 
stiffness, resulting in a similar stiffness of the aorta with respect to the carotids, is 
associated with microvascular brain damage (visible as WMH) and reduced cognitive 
performance.24 In a separate study that employed internal carotid artery velocity 
measurements, evidence was similarly found for an indirect link between blood 
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pressure and WMH through a shared coassociation with increasing arterial stiffness.25 
Apart from giving rise to SVD, increased capillary pulsations in the brain could also 
provide an explanation for widening of the ventricles. These pulsations are transferred 
to the intracranial CSF, presumably at the site of the choroid plexus where they cause a 
pulsatile increase in intraventricular CSF pressure during each systole.22 Increased 
intraventricular CSF pressure waves could cause an increased transmantle pressure 
gradient, giving rise to higher pressure waves at the periventricular than at the more 
superficial brain structures. This gradient may lead to enlargement of the ventricular 
volume through the so-called waterhammer effect, that continuously pushes the 
ventricular wall outward, ultimately causing ventricular dilatation.26 As the ventricles 
expand, forcing the brain out against the inner table of the calvarium, the sulci may 
decrease in size along with an increase of the ventricular volume. It is also conceivable 
that WMH and widening of the ventricles are not just epiphenomena of systemic 
arterial disease, but that they influence each other. MR-pathological studies have found 
that periventricular venous collagenosis - a gradual thickening of the walls of 
periventricular veins and venules with collagen occurring in normal aging - is increased 
in brains with WMH.27 In addition to venous collagenosis, MR-pathological studies have 
found arteriolar tortuosity and reduced vessel density in periventricular WMH.28 MR 
elastography has found softening of the brain in NPH patients, that was even more 
pronounced in the periventricular region29 and that partly decreased after shunt 
placement.30 Though no direct relationship with microvascular changes in the 
periventricular white matter was implied, it is a theoretical possibility that brains with 
impaired periventricular white matter will be less able to absorb the systolic pressure 
waves in the ventricles, resulting in more rapidly increasing and higher – and potentially 
more damaging – CSF pressure waves during each systole. 
 
The strength of our study includes the nature of the study population, which consists of 
a cohort of participants in a broad range of age groups, with both clinical and subclinical 
disease. The study is limited by the absence of participants with significant infarcts, who 
were excluded to prevent misinterpretation of ventricular and sulcal CSF volumes in our 
automated segmentation procedure. The group of excluded subjects was relatively 
older and contained a higher percentage of males and subjects with coronary heart 
disease and diabetes mellitus. The lack of an independent association in the current 
study of any cardiovascular risk factor with VV/SV - seeming to refute our hypothesis 
that ventricular enlargement reflects small vessel disease - may be explained by this 
truncation. It is possible that inclusion of participants carrying the highest rate of 
cardiovascular risk factors would have strongly contributed to our findings. Conversely, 
the fact that the associations described in the current study were observed in younger 
persons without significant infarcts strengthens our conclusions. An additional 
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limitation is the lack of measures of intra- or extracranial arterial stiffness, which could 
provide more direct evidence of the potential contribution of arterial stiffness to 
ventricular dilatation. 
 
In conclusion, our findings suggest that dilatation of the cerebral ventricles in patients 
with WMH may not be a mere reflection of SVD-based atrophy, but that it could be, at 
least partly, based on active expansion of the ventricles. This unexpected finding offers 
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The general objective of this thesis was to study the causes and consequences of 
ventricular dilatation in aging. For this purpose, we used ventricular shape analysis to 
study potential new MRI markers of cognitive decline in aging, subjective memory 
complaints and AD. In addition, we designed a volumetric measure that may objectively 
quantify the disproportionate ventricular dilatation that is characteristic of NPH. We 
investigated the value of this measure for the selection of candidates with NPH for 
ventricular shunting, studied its association with NPH-like symptoms in the general 
population and used the measure to explore a possible cardiovascular origin of cerebral 
ventricular dilatation. 
 
In chapter 2 a method of modeling and analyzing localized shape variations of ventricles 
was applied to a wide spectrum of cognitive levels. Each participant was assessed with 
the Mini-Mental State Examination (MMSE), yielding a study sample ranging from 
cognitively healthy to mild cognitive impairment, and from mild to advanced AD. The 
severity of periventricular atrophy was estimated as local enlargement of the 
ventricular surface relative to an average normal subject. We found that the severity of 
atrophy showed good correlation with MMSE score in the left thalamus, the left 
temporal horn, the left corona radiata, and the right caudate nucleus, increasing the 
number of potential biomarkers by means of ventricular shape analysis. 
 
In chapter 3 the method of ventricular shape modeling was directed towards 
investigating possible local shape differences between cognitively healthy and persons 
with subjective memory complaints. In this explorative study, we found outward 
displacement of the ventricular surface adjacent to the thalamus and the corona radiata 
in persons with subjective memory complaints, compared with controls, suggesting that 
these structures may be involved in the development of subjective memory complaints. 
In addition, uncorrected results showed tentative evidence of local shape differences in 
the ventricular surface of the corpus callosum, hippocampus (inferior temporal horn), 
and amygdala (superior temporal horn). 
 
Shunt surgery remains the standard treatment for NPH, despite high morbidity rates 
and lack of evidence indicating that shunt placement is effective in the management of 
this condition. Many diagnostic procedures have been described that may increase the 
probability of selecting the appropriate candidates for shunt surgery. In chapter 4 we 
studied the potential of volumetric assessment to distinguish between patients who 
respond to ventricular shunt surgery and those who do not. The preoperative ratio of 
ventricular volume and sulcal CSF volume was correlated with postoperative 
improvement in gait impairment, cognitive impairment, and bladder function. We 
found no difference in the mean preoperative ratio of ventricular volume and sulcal CSF 
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volume between subjects who improved on gait, cognition or bladder function and 
those who did not. This indicates that volumetric assessment has no predictive value in 
differentiating between NPH patients who will respond to shunt surgery and those who 
do not. 
 
In chapter 5 we examined the association of disproportionate ventricular dilatation 
(expressed as the upper quartile of the ratio of ventricular volume and sulcal CSF 
volume) with gait impairment, cognitive impairment, and bladder dysfunction in a 
cohort of elderly persons from the general population. We found that those with 
disproportionate ventricular dilatation were more likely to have impaired gait and 
cognition. In addition, they were also more likely to have both impaired gait and 
impaired cognition. These associations were independent of white matter 
hyperintensity (WMH) volume. The presence of the radiological hallmark of NPH in 
persons with NPH triad symptoms in the general population raises the question 
whether more individuals could benefit from ventricular shunting. 
 
Elaborating on earlier studies that suggested a vascular origin of disproportionate 
ventricular dilatation in NPH, in chapter 6 we hypothesized that ventricular volume out 
of proportion to sulcal CSF volume is caused by white matter atrophy resulting from 
small vessel disease. In order to quantify disproportionate ventricular dilatation, we 
used the ratio of ventricular volume and sulcal CSF volume (VV/SV) that was described 
in chapters 4 and 5. WMH volume was chosen to represent small vessel disease. We 
found that WMH volume was positively correlated with both ventricular volume and 
sulcal CSF volume. However, WMH volume showed a negative correlation with sulcal 
CSF volume. Our findings suggest that dilatation of the ventricles in patients with white 
matter hyperintensities is not a mere reflection of small vessel disease based atrophy, 
but that it may, at least partly, be based on active expansion of the ventricles. This 
unexpected finding sheds new light on the pathophysiology of NPH. 
Future studies 
Early detection 
As our explorative study on ventricular shape differences in persons with subjective 
memory complaints discovered, anatomical differences compared to controls could be 
detected using ventricular shape analysis in the absence of objective changes in 
cognitive impairment. Further studies are necessary to investigate its possible value for 
the early detection of neurodegenerative disorders that are characterized by localized 
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or general cerebral atrophy, such as Frontotemporal Dementia and Parkinson’s Disease 
dementia. 
Arterial stiffness 
The theory of a vascular origin of NPH, which was supported by the findings of chapter 
6, deserves further exploration with the inclusion of other parameters of 
arteriosclerosis and mechanical stress such as arterial stiffness. Studies of arterial 
stiffness in persons with disproportionate ventricular dilation could reinforce the 
hypothesis that propagation of pulsatile energy into the vascular bed of end organs 
such as the brain can lead to microvascular brain damage. Further knowledge of the 
relationship between arterial stiffness and disproportionate ventricular dilation could 
perhaps aid in the selection of candidates for shunt surgery. 
Multimodality approach 
The studies set out in this thesis are all based on post-processing of qualitative 1.5T 
based MRI images. Further possibilities for the study of intracranial CSF compartments 
lie in the field of higher field imaging (3T and up), as well as a combined approach using 
quantitative MRI techniques like brain perfusion imaging, phase-contrast cine MRI and 
MR elastography. In addition, data from neuroimaging studies combined with 
cerebrospinal fluid markers (amino acids, viscosity, pressure) or serum markers may 
lead to the discovery of new biomarkers of treatable NPH or the refinement of existing 
ones. 
Longitudinal studies 
The available literature on neuroimaging in Normal Pressure Hydrocephalus has until 
now focused on cross-sectional studies of ventricular dilatation, with the cause of 
dilatation being inferred from a number of features including the proportion between 
ventricular volume and sulcal CSF volume, as well as aqueductal stroke volume, the 
integrity of the periventricular white matter and the absence of a CSF flow obstruction. 
Longitudinal studies may be helpful in determining whether changes in the shape and 
size of the ventricular system occur due to (intermittently) elevated cerebrospinal fluid 











De algemene doelstelling van dit proefschrift was het onderzoeken van de oorzaken en 
gevolgen van ventriculaire dilatatie bij veroudering. Hiervoor hebben we de vorm van 
de ventrikels geanalyseerd om potentiële nieuwe MRI markers voor cognitieve 
achteruitgang te bestuderen bij veroudering, subjectieve geheugenklachten en de 
Ziekte van Alzheimer. Daarnaast hebben we een volumetrische maat ontworpen die op 
objectieve wijze de disproportionele ventriculaire dilatatie kan kwantificeren die 
karakteristiek is voor NPH (Normal Pressure Hydrocephalus). We hebben de waarde van 
deze maat onderzocht voor het selecteren van kandidaten met NPH ten behoeve van 
het plaatsen van een ventriculaire shunt, evenals de associatie van deze maat met in de 
algemene populatie voorkomende bij NPH passende symptomen en hebben de maat 
gebruikt om een mogelijke cardiovasculaire origine van cerebrale ventriculaire dilatatie 
te onderzoeken. 
 
In hoofdstuk 2 werd een methode voor modellering en analyse van lokale variaties in 
ventriculaire vorm toegepast bij een breed spectrum van cognitieve niveaus. Bij elke 
deelnemer werd de Mini-Mental State Examination (MMSE) afgenomen, waardoor de 
onderzoekspopulatie ingedeeld kon worden van cognitief gezond tot milde cognitieve 
achteruitgang en van milde tot geavanceerde Ziekte van Alzheimer. De mate van 
periventriculaire atrofie werd gedefinieerd als lokale vergroting van het ventriculaire 
oppervlak ten opzichte van de gemiddelde normale deelnemer. We stelden vast dat de 
mate van atrofie goed correleerde met MMSE score ter plaatse van de linker thalamus, 
de linker temporaal hoorn, de linker corona radiata en de rechter nucleus caudatus. 
Deze anatomische gebieden kunnen in de toekomst wellicht toegevoegd worden aan de 
lijst van erkende ventriculaire biomarkers. 
 
In hoofdstuk 3 werd de methode van analyse van de ventriculaire vorm toegepast voor 
het onderzoeken van mogelijke lokale verschillen in ventriculaire vorm tussen cognitief 
gezonden en personen met subjectieve geheugenklachten. In deze exploratieve studie 
constateerden we buitenwaartse verplaatsing van het ventriculaire oppervlak grenzend 
aan de thalamus en de corona radiata bij personen met subjectieve geheugenklachten 
in vergelijking tot controles, hetgeen suggereert dat deze structuren mogelijk betrokken 
zijn bij de ontwikkeling van subjectieve geheugenklachten. Daarnaast toonden 
ongecorrigeerde resultaten tentatief bewijs voor lokale vorm verschillen in het 
ventriculaire oppervlak van het corpus callosum, de hippocampus (inferieure 
temporaalhoorn) en amygdala (superieure temporaalhoorn). 
 
Shunt chirurgie maakt nog steeds onderdeel uit van de reguliere behandeling van NPH, 
ondanks een hoge morbiditeit en matig bewijs dat het plaatsen van een shunt effectief 
is bij de behandeling van deze aandoening. Er zijn meerdere vormen van diagnostiek 
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beschreven die de kans op het selecteren van geschikte kandidaten voor shunt chirurgie 
kunnen verhogen. In hoofdstuk 4 onderzochten we het mogelijke voordeel van 
volumetrische evaluatie voor het differentiëren tussen patiënten die een gunstig effect 
zouden ondervinden van een ventriculaire shunt en degenen bij wie dit geen nuttige 
behandeling zou blijken. De pre-operatieve ratio van ventriculair volume en sulcaal CSF 
(hersenvocht) volume werd gecorreleerd aan postoperatieve verbetering in lopen, 
cognitie en blaasfunctie. We stelden geen verschil vast in de gemiddelde ratio tussen de 
personen die post-operatief een verbetering in lopen, cognitie of blaasfunctie 
ondervonden en de personen bij wie de beperkingen niet verbeterden. Dit geeft aan dat 
volumetrische evaluatie geen voorspellende waarde heeft bij het differentiëren tussen 
NPH patiënten die gunstig zullen reageren op shunt chirurgie en degenen die dat niet 
zullen doen. 
 
In hoofdstuk 5 onderzochten we de associatie tussen disproportionele ventriculaire 
dilatatie (uitgedrukt als het bovenste kwartiel van de ratio tussen ventriculair volume en 
sulcaal CSF volume) met loopstoornissen, cognitieve achteruitgang en blaas dysfunctie 
in een cohort van oudere personen uit de algemene populatie. We stelden vast dat 
degenen met disproportionele ventriculaire dilatatie meer kans hadden op 
loopstoornissen of cognitieve achteruitgang. Daarnaast hadden ze meer kans op een 
combinatie van zowel loopstoornissen als cognitieve achteruitgang. Deze associaties 
waren onafhankelijk van het volume van witte stof hyperintensiteiten (WMH). De 
aanwezigheid van het meest karakteristieke radiologische kenmerk van NPH bij 
personen uit de algehele populatie met symptomen van de NPH trias roept de vraag op 
of meer personen baat zouden kunnen hebben bij shunt chirurgie. 
 
Voortbordurend op eerdere studies waaruit een mogelijke vasculaire origine van 
disproportionele ventriculaire dilatatie in NPH bleek, hebben we in hoofdstuk 6 de 
hypothese geformuleerd dat ventriculair volume in disproportie met sulcaal CSF volume 
veroorzaakt wordt door atrofie van de witte stof als gevolg van microangiopathie. Om 
disproportionele ventriculaire dilatatie te kunnen kwantificeren hebben we de ratio 
gebruikt van ventriculair volume en sulcaal CSF volume (VV/SV) die eerder beschreven 
werd in hoofdstukken 4 en 5. WMH volume werd gekozen om microangiopathie te 
vertegenwoordigen. We stelden vast dat WMH volume positief gecorreleerd was met 
zowel ventriculair volume als sulcaal CSF. Echter, WMH volume toonde een negatieve 
correlatie met sulcaal CSF volume. Onze bevindingen suggereren dat dilatatie van de 
ventrikels bij patiënten met WMH niet uitsluitend een weerspiegeling is van aan 
microangiopathie gerelateerde atrofie, maar dat die, in ieder geval gedeeltelijk, kan 
berusten op actieve expansie van de ventrikels. Deze onverwachte bevinding werpt 




Zoals onze exploratieve studie naar veranderingen van de ventriculaire vorm bij 
personen met subjectieve geheugenklachten liet zien, konden middels analyse van de 
ventriculaire vorm anatomische verschillen worden waargenomen tussen personen met 
subjectieve geheugenklachten en controles, terwijl middels cognitieve testen geen 
objectiveerbare verschillen waarneembaar waren. Verdere studies lijken noodzakelijk 
om de mogelijke waarde van ventriculaire vorm analyse te onderzoeken bij 
neurodegeneratieve aandoeningen die gekarakteriseerd worden door lokale of 
gegeneraliseerde cerebrale atrofie, zoals Frontotemporale Dementie en de Ziekte van 
Parkinson. 
Arteriële stijfheid 
De theorie van een vasculaire origine van NPH, welke ondersteund wordt door de 
bevindingen in hoofdstuk 6, verdient een verdere exploratie met de inclusie van andere 
parameters van atherosclerose en mechanische stress zoals arteriële stijfheid. Studies 
naar arteriële stijfheid bij personen met disproportionele ventriculaire dilatatie kunnen 
wellicht de hypothese versterken dat voortgeleiding van pulsatiele energie naar het 
vasculaire bed van eindorganen zoals de hersenen kan leiden tot microvasculaire 
hersenschade. Een grotere kennis over de relatie tussen arteriële stijfheid en 
disproportionele ventriculaire dilatatie zou kunnen leiden tot een betere selectie van 
kandidaten voor shunt chirurgie. 
Multimodale benadering 
De in dit proefschrift beschreven studies zijn alle gebaseerd op post-processing van 
kwalitatieve op 1.5T gemaakte MRI onderzoeken. Verdere mogelijkheden voor de 
studie van intracraniële CSF compartimenten liggen in het veld van beeldvorming met 
een hogere veldsterkte (3T en hoger), evenals een gecombineerde benadering met 
kwantitatieve MRI technieken zoals hersenperfusie, fase-contrast dynamische MRI en 
MR-elastografie. Daarnaast kan data van beeldvorming studies gecombineerd worden 
met CSF parameters (aminozuren, viscositeit, druk) of serum markers, hetgeen zou 
kunnen leiden tot de ontdekking van nieuwe biomarkers van behandelbare NPH of 
verfijning van de huidige. 
Longitudinale studies 
De beschikbare literatuur met betrekking tot neuroradiologische beeldvorming van NPH 
heeft zich tot nu toe gericht op cross-sectionele studies van ventriculaire dilatatie, 
waarbij de oorzaak van de dilatatie wordt afgeleid uit een aantal kenmerken, zoals de 
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verhouding tussen ventriculair volume en sulcaal CSF volume, het aqueductaal slag 
volume, de integriteit van de periventriculaire witte stof of het gebrek aan obstructie 
van afvloed van het CSF. Longitudinale studies kunnen nuttig zijn bij het vaststellen of 
veranderingen in de vorm en grootte van het ventrikelstelsel optreden als gevolg van 
(intermitterend) verhoogde CSF druk, dan wel als gevolg van verlies van 
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